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Abstract: Das Ziel der vorliegenden Arbeit war, klinische Anwendungen der funktionellen Magnetreso-
nanztomographie (fMRT) im mesialen Temporallappen (MTL) zu untersuchen, um damit die klinische
Diagnostik bei der mesialen Temporallappenepilepsie (MTLE) zu verbessern. Die MTLE ist die häu-
figste Form fokaler Epilepsien (Engel et al 1997). Deren Behandlung erfolgt mit Hilfe antikonvulsiver
Medikamente (AED) oder, wenn die Anfälle trotz medikamentöser Behandlung weiterbestehen, mit einem
epilepsiechirurgischen Eingriff. Beide Behandlungsmethoden können die kognitiven Funktionen eines Pa-
tienten beeinträchtigen. Weil intakte kognitive Funktionen wichtig für die Lebensqualität sind (Trimble
1994), ist eine sorgfältige und umfassende Untersuchung von möglichen Therapieeffekten unabdingbar.
Dies wird durch die neuropsychologische Diagnostik, die sich zunehmend auch fMRT zu Nutze macht, be-
werkstelligt. Individualdiagnostische fMRT-Untersuchungen sind wegen der schwachen Signalstärken, ins-
besondere im Bereich der mesialen Temporallappen (MTL), problematisch. Eine mögliche Lösung dieses
Problems könnte sein, das Signal pharmakologisch zu verstärken. Weil diesbezüglich positive Erfahrun-
gen mit Koffein in primär motorischen und visuellen Arealen vorliegen (Mulderink et al 2002), wurde in
einer ersten Studie untersucht, ob Koffein geeignet ist, in der klinischen fMRT- Individualdiagnostik das
Signal zu verstärken. Mit Hilfe einer Längsschnittstudie (pro Versuchsperson acht Wiederholungsmes-
sungen mit vier Baseline-, zwei Placebo- und zwei Koffeinmessungen) wurden drei funktionelle Domänen,
das primär visuelle und das primär motorische Areal sowie die MTL untersucht. In unserer Studie war
Koffein viel weniger wirksam als erwartet, insbesondere konnten wir im MTL keinen Einfluss nachweisen.
Vielmehr wirkte Koffein domänenspezifisch, sogar innerhalb ein und derselben Versuchsperson und ver-
stärkte zudem die interindividuelle Variabilität. Unsere Studie legt deshalb nahe, dass Koffein nicht
als Signalverstärker für klinische fMRT-Studien verwendet werden sollte. Hinsichtlich der medikamen-
tösen Epilepsiebehandlung könnte der Gebrauch von fMRT die Diagnostik kognitiver Nebenwirkungen
wesentlich verbessern, weil im Gegensatz zur neuropsychologischen Untersuchung mehrere konfundierende
Variablen kontrolliert werden können (z.B. Anfälle, interiktale Entladungen, Stimmung). Bevor fMRT
dafür eingesetzt werden kann, muss die Methode hinsichtlich ihrer längerfristigen Wiederholbarkeit va-
lidiert werden. Dieses Ziel wurde in der zweiten Studie verfolgt, indem die fMRT-Untersuchungen der
Roland Hometown Walking Task (Jokeit et al 2001c) zur Aktivierung des MTL sechsmal wiederholt
wurde. Es konnte gezeigt werden, dass es mit Hilfe serieller fMRT-Langzeitgruppenstudien möglich zu
sein scheint AED Nebenwirkungen nachzuweisen. Die Kenntnis der Variabilitätshöhe von wiederholten
fMRT-Untersuchungen hilft in zukünftigen Studien zwischen der Variabilität, die durch die Methode
erklärt werden kann und dem tatsächlichen Einfluss von Medikamenten zu unterscheiden. Die dritte
Studie befasste sich mit der funktionellen Darstellbarkeit der Amygdala im Rahmen der prächirurgischen
fMRT-Diagnostik. Letztere wurde bisher vorwiegend dazu verwendet, Sprach- und Gedächtnisfunktionen
zu orten und zu lateralisieren, um unerwünschte Folgen von Epilepsieoperationen zu vermeiden (Detre
2004). Es konnte gezeigt werden, dass es möglich ist, die Amygdala im Einzelfall funktionell zu unter-
suchen. Die dazu verwendete fMRT-Aufgabe beinhaltete Videosequenzen, in denen angsterfüllte Gesichter
(Aktivierungsbedingung) und Landschaftsaufnahmen (Kontrollbedingung) zu sehen waren. Diese Auf-
gabe aktivierte die Amygdala individuell stark, zuverlässig, wiederholbar und spezifisch. Die individuelle
Darstellbarkeit der Amygdala erlaubt zukünftig, klinische Konsequenzen der Resektion zu untersuchen.
Dazu gehören zum Beispiel die emotionale und soziale Kognition, die eng mit der Funktionstüchtigkeit
der Amygdala in Zusammenhang gebracht wird. Die Kombination der Amygdala-Messung mit einer Auf-
gabe zur Gedächtnismessung erhöht zudem die Zuverlässigkeit und Genauigkeit der Lateralisierung der
epileptogenen Seite bei Patienten mit MTLE. The present thesis was aimed at investigating clinical func-
tional magnetic resonance imaging (fMRI) applications within the mesial temporal lobe (MTL). These
applications were considered to improve the clinical fMRI diagnostics in mesial temporal lobe epilepsy
(MTLE), the most frequent form of focal epilepsy (Engel 1996). Mesial temporal lobe epilepsy is mainly
treated with antiepileptic drugs (AED) or, when the seizures are refractory, by resective surgery. Both
therapies may have substantial influence on patients’ cognitive profiles. A comprehensive MTLE care
includes the evaluation and the prevention of negative treatment effects. This is provided by neuropsy-
chological examination and increasingly by fMRI. The importance of evaluating the cognitive side-effects
of treatments is based on the fact that disturbances of cognitive function are one of the major influences
on quality of life in individuals with epilepsy (Trimble 1994). One of the major difficulties in the appli-
cation of fMRI in a clinical context is the low BOLD contrast in individual subjects, especially within
MTL, where the SNR is genuinely low. Because caffeine has recently been proposed as an effective BOLD
contrast booster in functional MRI studies for studies confronted with a low SNR (Mulderink et al 2002),
we evaluated caffeine as a contrast booster for single-case fMRI- investigations. We chose an extended
study design with each person acting as their own control in four baseline, two placebo and two caffeine
measurements and investigated the effect of caffeine in primary visual, primary motor area and the MTL.
We found that caffeine is a far less effective BOLD contrast booster than expected and we clearly failed
to find any effects following caffeine administration within the MTL. Caffeine related BOLD-contrast
changes were even more domain specific, even within the same subject. Moreover, caffeine may enhance
inter-individual variability and reduce the signal in certain subjects. Our results therefore discourage the
use of caffeine as a BOLD contrast booster in a clinical context. Regarding the diagnostics of pharma-
cologically induced cognitive dysfunctions, we were able to plan future pharmaco-fMRI studies targeting
cognitive side-effects of AEDs. The application of fMRI within this field could improve the diagnostics
of pharmacologically induced cognitive side-effects. In contrast to neuropsychological testing, it allows
one to examine cognitive side-effects directly and specifically in the MTL. The present study, which
investigated the Roland Hometown Walking task (Jokeit et al 2001c) within the MTL over six serial
fMRI-scans provides data on the variability inherent in the long-term-stability of fMRI results within
MTL. Our study demonstrated that the application of fMRI in studying the effects of AED treatments
on brain functions is possible, but it may be restricted to its application in longitudinal group studies with
multiple scans. Knowledge about the magnitude of variability aids in future AED studies in distinguish-
ing between variations inherent in the examination method and changes in the subject’s brain induced
by pharmacological treatment. The third study was aimed at expanding presurgical fMRI-diagnostics
with the functional investigation of an additional structure, namely the amygdala. Functional MRI is
used to examine regional changes in brain function associated with seizures. To date, presurgical fMRI
is mainly used to assess localisation and lateralisation of language and memory to prevent postsurgical
impairments (Detre 2004). Our study demonstrated the feasibility of additionally imaging the amygdala
in presurgical fMRI- diagnostics in individual subjects. By employing dynamic fearful faces contrasted by
bland landscapes our paradigm activated both amygdalae strongly, robustly, replicably and specifically
in individual subjects. The ease of administration and the low cognitive demand on patients increases
the practicality of this tool for studying of MTL structures.
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1 Zusammenfassung
Das Ziel der vorliegenden Arbeit war, klinische Anwendungen der funktionellen Magnet-
resonanztomographie (fMRT) im mesialen Temporallappen (MTL) zu untersuchen, um
damit die klinische Diagnostik bei der mesialen Temporallappenepilepsie (MTLE) zu
verbessern. Die MTLE ist die häufigste Form fokaler Epilepsien (Engel et al 1997). Deren
Behandlung erfolgt mit Hilfe antikonvulsiver Medikamente (AED) oder, wenn die Anfälle
trotz medikamentöser Behandlung weiterbestehen, mit einem epilepsiechirurgischen
Eingriff. Beide Behandlungsmethoden können die kognitiven Funktionen eines Patienten
beeinträchtigen. Weil intakte kognitive Funktionen wichtig für die Lebensqualität sind
(Trimble 1994), ist eine sorgfältige und umfassende Untersuchung von möglichen
Therapieeffekten unabdingbar. Dies wird durch die neuropsychologische Diagnostik, die
sich zunehmend auch fMRT zu Nutze macht, bewerkstelligt.
Individualdiagnostische fMRT-Untersuchungen sind wegen der schwachen Signalstärken,
insbesondere im Bereich der mesialen Temporallappen (MTL), problematisch. Eine
mögliche Lösung dieses Problems könnte sein, das Signal pharmakologisch zu
verstärken. Weil diesbezüglich positive Erfahrungen mit Koffein in primär motorischen und
visuellen Arealen vorliegen (Mulderink et al 2002), wurde in einer ersten Studie
untersucht, ob Koffein geeignet ist, in der klinischen fMRT-Individualdiagnostik das Signal
zu verstärken. Mit Hilfe einer Längsschnittstudie (pro Versuchsperson acht Wieder-
holungsmessungen mit vier Baseline-, zwei Placebo- und zwei Koffeinmessungen)
wurden drei funktionelle Domänen, das primär visuelle und das primär motorische Areal
sowie die MTL untersucht. In unserer Studie war Koffein viel weniger wirksam als
erwartet, insbesondere konnten wir im MTL keinen Einfluss nachweisen. Vielmehr wirkte
Koffein domänenspezifisch, sogar innerhalb ein und derselben Versuchsperson und
verstärkte zudem die interindividuelle Variabilität. Unsere Studie legt deshalb nahe, dass
Koffein nicht als Signalverstärker für klinische fMRT-Studien verwendet werden sollte.
Hinsichtlich der medikamentösen Epilepsiebehandlung könnte der Gebrauch von fMRT
die Diagnostik kognitiver Nebenwirkungen wesentlich verbessern, weil im Gegensatz zur
neuropsychologischen Untersuchung mehrere konfundierende Variablen kontrolliert
werden können (z.B. Anfälle, interiktale Entladungen, Stimmung). Bevor fMRT dafür ein-
gesetzt werden kann, muss die Methode hinsichtlich ihrer längerfristigen Wiederholbarkeit
validiert werden. Dieses Ziel wurde in der zweiten Studie verfolgt, indem die fMRT-
Untersuchungen der Roland Hometown Walking Task (Jokeit et al 2001c) zur Aktivierung
des MTL sechsmal wiederholt wurde. Es konnte gezeigt werden, dass es mit Hilfe
serieller fMRT-Langzeitgruppenstudien möglich zu sein scheint AED Nebenwirkungen
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nachzuweisen. Die Kenntnis der Variabilitätshöhe von wiederholten fMRT-
Untersuchungen hilft in zukünftigen Studien zwischen der Variabilität, die durch die
Methode erklärt werden kann und dem tatsächlichen Einfluss von Medikamenten zu
unterscheiden.
Die dritte Studie befasste sich mit der funktionellen Darstellbarkeit der Amygdala im
Rahmen der prächirurgischen fMRT-Diagnostik. Letztere wurde bisher vorwiegend dazu
verwendet, Sprach- und Gedächtnisfunktionen zu orten und zu lateralisieren, um
unerwünschte Folgen von Epilepsieoperationen zu vermeiden (Detre 2004). Es konnte
gezeigt werden, dass es möglich ist, die Amygdala im Einzelfall funktionell zu
untersuchen. Die dazu verwendete fMRT-Aufgabe beinhaltete Videosequenzen, in denen
angsterfüllte Gesichter (Aktivierungsbedingung) und Landschaftsaufnahmen (Kontroll-
bedingung) zu sehen waren. Diese Aufgabe aktivierte die Amygdala individuell stark,
zuverlässig, wiederholbar und spezifisch. Die individuelle Darstellbarkeit der Amygdala
erlaubt zukünftig, klinische Konsequenzen der Resektion zu untersuchen. Dazu gehören
zum Beispiel die emotionale und soziale Kognition, die eng mit der Funktionstüchtigkeit
der Amygdala in Zusammenhang gebracht wird. Die Kombination der Amygdala-Messung
mit einer Aufgabe zur Gedächtnismessung erhöht zudem die Zuverlässigkeit und
Genauigkeit der Lateralisierung der epileptogenen Seite bei Patienten mit MTLE.
Summary
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2 Summary
The present thesis was aimed at investigating clinical functional magnetic resonance
imaging (fMRI) applications within the mesial temporal lobe (MTL). These applications
were considered to improve the clinical fMRI diagnostics in mesial temporal lobe epilepsy
(MTLE), the most frequent form of focal epilepsy (Engel 1996). Mesial temporal lobe
epilepsy is mainly treated with antiepileptic drugs (AED) or, when the seizures are
refractory, by resective surgery. Both therapies may have substantial influence on
patients’ cognitive profiles. A comprehensive MTLE care includes the evaluation and the
prevention of negative treatment effects. This is provided by neuropsychological
examination and increasingly by fMRI. The importance of evaluating the cognitive side-
effects of treatments is based on the fact that disturbances of cognitive function are one of
the major influences on quality of life in individuals with epilepsy (Trimble 1994).
One of the major difficulties in the application of fMRI in a clinical context is the low BOLD
contrast in individual subjects, especially within MTL, where the SNR is genuinely low.
Because caffeine has recently been proposed as an effective BOLD contrast booster in
functional MRI studies for studies confronted with a low SNR (Mulderink et al 2002), we
evaluated caffeine as a contrast booster for single-case fMRI-investigations. We chose an
extended study design with each person acting as their own control in four baseline, two
placebo and two caffeine measurements and investigated the effect of caffeine in primary
visual, primary motor area and the MTL. We found that caffeine is a far less effective
BOLD contrast booster than expected and we clearly failed to find any effects following
caffeine administration within the MTL. Caffeine related BOLD-contrast changes were
even more domain specific, even within the same subject. Moreover, caffeine may
enhance inter-individual variability and reduce the signal in certain subjects. Our results
therefore discourage the use of caffeine as a BOLD contrast booster in a clinical context.
Regarding the diagnostics of pharmacologically induced cognitive dysfunctions, we were
able to plan future pharmaco-fMRI studies targeting cognitive side-effects of AEDs. The
application of fMRI within this field could improve the diagnostics of pharmacologically
induced cognitive side-effects. In contrast to neuropsychological testing, it allows one to
examine cognitive side-effects directly and specifically in the MTL. The present study,
which investigated the Roland Hometown Walking task (Jokeit et al 2001c) within the MTL
over six serial fMRI-scans provides data on the variability inherent in the long-term-
stability of fMRI results within MTL. Our study demonstrated that the application of fMRI in
studying the effects of AED treatments on brain functions is possible, but it may be
restricted to its application in longitudinal group studies with multiple scans. Knowledge
Summary
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about the magnitude of variability aids in future AED studies in distinguishing between
variations inherent in the examination method and changes in the subject’s brain induced
by pharmacological treatment.
The third study was aimed at expanding presurgical fMRI-diagnostics with the functional
investigation of an additional structure, namely the amygdala. Functional MRI is used to
examine regional changes in brain function associated with seizures. To date, presurgical
fMRI is mainly used to assess localisation and lateralisation of language and memory to
prevent postsurgical impairments (Detre 2004). Our study demonstrated the feasibility of
additionally imaging the amygdala in presurgical fMRI-diagnostics in individual subjects.
By employing dynamic fearful faces contrasted by bland landscapes our paradigm
activated both amygdalae strongly, robustly, replicably and specifically in individual
subjects. The ease of administration and the low cognitive demand on patients increases
the practicality of this tool for studying amygdala-functions and deficits in a clinical context.
The feasibility of imaging the amygdala in individual cases allows for the evaluation of
possible clinical implications for amygdala-related functions including emotional and social
processing following temporal lobe surgery. The combination of the fearful face paradigm
and the Roland’s Hometown Walking Task increases the reliability of lateralisation in
MTLE patients and, therefore, provides a more detailed and reliable presurgical mapping
of MTL structures.
Theoretical background
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3 Theoretical background
There is a substantial desire to apply functional magnetic resonance imaging (fMRI) to the
non-invasive investigation of brain function in both basic and clinical neuroscience.
Generally, the use of fMRI in a clinical setting presents challenges beyond those
encountered in basic neuroscience, where mostly group studies with healthy volunteers
are used. Problems include for example the small signal-changes or artefacts induced by
motion or susceptibility. The distinct advantages of fMRI on the other hand include its non-
invasiveness, relatively high spatial and for many purposes sufficient temporal resolution,
ease of imaging the underlying anatomy, and the high accessibility of MR scanners.
In the present report, the application of fMRI in epilepsy is investigated. The use of fMRI in
this context has received considerable attention for a variety of reasons. First, epilepsy is
in many instances a functional disorder that must not necessarily be accompanied by
gross abnormalities on structural imaging. Accordingly, fMRI has been used to examine
regional changes in brain function associated with seizures, as has previously been
demonstrated with radionuclide imaging. Second, fMRI has been used to assess
localisation of language, memory and other functions as part of the preoperative
evaluation for epilepsy surgery of patients with medically refractory epilepsy (Detre 2004).
The use of fMRI in this context is very attractive, because it allows for the validation of
fMRI-results with other brain mapping techniques (e.g. the intracarotid amobarbital test or
electrocorticographic mapping) or the postsurgical outcome. Third and finally, fMRI allows
for the study of pharmacologically induced effects (Honey et al 2004; Leslie et al 2000)
and could in future be an attractive tool to study cognitive side-effects of antiepileptic
drugs (AED).
3.1 The mesial temporal lobe epilepsy (MTLE)
In the following chapters, background information about mesial temporal lobe epilepsy
(MTLE) will be provided, in order to support the understanding of fMRI application in this
syndrome.
3.1.1 Neurological characteristics of MTLE
Mesial temporal lobe epilepsy is the most frequent form of focal epilepsy in adults (Engel
et al 1997) and epileptic seizures typically arise from the inner part of the mesial temporal
lobe (MTL) (Mathern et al 2002). Seizures are associated with specific anatomic changes
in the deep areas of the temporal lobe (TL), including tissue shrinkage, cell loss, and
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reactive gliosis (Mathern et al 2002). Neuron cells are replaced by the glial cells, leading
to atrophy and sclerosis of the mesial temporal areas (Kalviainen et al 2002; Mathern et al
2002). Today it has been concluded that MTL sclerosis is both a cause and an effect of
seizures.
Risk factors for MTLE include febrile seizures (frequently prolonged ones), meningitis,
encephalitis, or head trauma (Annegers et al 1996; Jokeit et al 2004). There is often a
latency of 5 to 10 years between the brain insult and the onset of seizures (Berg et al
2003; French et al 1993).
Seizure semiology in patients with temporal lobe epilepsy includes simple partial seizures
(auras), complex partial, or secondarily generalised tonic–clonic seizures. The simple
partial seizure is an ictal event generated predominantly by MTL structures. Conscious
awareness is preserved. It usually involves symptoms referable to this area such as a
sensation of epigastric rising, emotional changes (most commonly fear), and occasionally
olfactory or gustatory hallucinations. The classical mesial temporal simple partial seizures
characteristically occur in isolation, reflecting the fact that there is little transfer across the
human hippocampal commissure, so that seizures originating in one hippocampus remain
unilateral for long periods of time and may never propagate to the contralateral side to
produce impairment of consciousness (Devinsky 2004; Engel 1996).
Complex partial seizures impair consciousness and memory. When these seizures occur,
they also have the characteristic features of mesial temporal involvement. There is
typically a stare with arrest of motion, followed by altered responsiveness, oroalimentary
and gestural automatism, and later reactive automatism’s lasting typically one to two
minutes (Devinsky 2004; Engel 1996).
Secondarily generalised seizures can occur with or without prior simple or complex partial
seizures. These seizures occur only rarely, probably due to the fact that currently used
AEDs are effective against the ictal evolution that leads to these events but not against
the simple and complex partial seizures of MTL origin (Devinsky 2004; Engel 1996).
For individual patients, TL seizures are usually stereotypic in their symptoms and duration.
Postictal confusion, tiredness, and amnesia are common. Postictal symptoms can help to
lateralise the focus (e.g. impairments in verbal memory and naming after left-sided
seizures and geographic disorientation after right-sided seizures). Some patients are
unaware of the mental lapses, denying any impairment in level of consciousness
(Devinsky 2004; Engel 1996).
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3.1.2 Neuropsychological characteristics of MTLE
Mesial temporal lobe epilepsy has become the best neuropsychologically investigated
type of epilepsy because of its high prevalence and its underlying structural lesion in a
circumscribed brain structure.
Mesial temporal lobe structures, i.e. hippocampus, parahippocampus and amygdala,
differentially contribute to memory processing. The amygdala refers additionally to mood
and emotional processing, including social cognition.
Memory
The leading functional symptoms of the majority of patients with MTLE are deficits of
episodic memory (Eichenbaum 1999; McGaugh 2000). The term episodic memory refers
to the cognitive processes that enable the explicit recollection of unique events and the
context in which they occurred. These include the transformation of an experience into an
enduring memory trace (memory encoding) and the subsequent recollection of the event
at a later time (memory retrieval). These processes mainly depend on a functionally intact
hippocampus (Baddeley 2001). The exact role of the hippocampus is still a matter of
controversy. It is suggested that elemental cognitive processes, including processing
associations, organising an episode as sequence of events and ‘relational networking’,
mediate these complex memory functions. Within associative representations, the
hippocampus seems to support both encoding (Sperling et al 2003) and retrieval
processes (Maguire et al 2003) such as in the retrieval of autobiographical experiences.
Even more, the level of detail, personal significance and emotionality seems to contribute
to hippocampal activation of autobiographical memories (Addis et al 2004). ‘Relational
networking‘ terms the linking of episodic memories into relational networks in order to
abstract the common features among related memories. Within this model, the
hippocampus constructs relational networks that co-ordinate memories stored in the
cerebral cortex (Eichenbaum 2004).
The role of the parahippocampus is suggested to held neocortical perceptually and
conceptually processed information (Eichenbaum 2000) and is responsive for spatial
memory such as visual imagery and retrieval of landmarks and their location (Rosenbaum
et al 2004). Interestingly, the hippocampus is suggested not to be needed for the storage
and recovery of a spatial layout. It seems to be engaged only in the retrieval of recent
spatial memory, where the hippocampus binds details and therefore facilitates the
extraction of schematic spatial information (Mellet et al 2000). In contrast, the
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hippocampus does not participate in the retrieval of remote spatial memory, because the
schematic representation is already completed and cortically represented (Rosenbaum et
al 2004).
The amygdala finally is important in enhancing the retention of emotionally-valenced
information (Zald 2003). This is best seen in the fact that emotionally arousing information
is recalled and recognised better than emotionally neutral material.
A model of memory impairment in epilepsy cannot be concluded in these detail. Memory
deficits in MTLE patients may vary in severity from mild subjective memory impairment to
persistent amnesia that largely prevents the patient from learning any new information
(Hermann et al 1997). The episodic memory, that is the explicit acquisition and later
retrieval of new information, is particularly impaired. Obviously, this also leads to the
impairment of remote (biographical) memory, although retrograde mnestic problems
caused by seizures cannot be completely excluded (Bergin et al 2000). Such findings are
in line with suggestions that the encoding of episodic information is the main problem in
MTLE. However, associations of hippocampal MR spectroscopic imaging and
confrontation naming indicate that temporomesial structures participate also in retrieval
processes (Bell et al 2000; Sawrie et al 2000).
The left TL and right TL differentially contribute to material-specific memory, with the left
hemisphere specialised in the processing of verbal material and the right hemisphere in
processing of non-verbal, perceptual details or spatial attributes of material. In patients
with MTLE, memory impairment tends to be material specific as a function of lateralisation
of the epileptic focus (Helmstaedter et al 1997; Moscovitch et al 2002).
Mood and emotional processing
Further functional impairments probably related to temporomesial limbic structures refer to
mood and social cognition. In MTLE patients, the incidence of depressive mood disorders
is markedly increased, whereas multiple etiological mechanisms such as psychosocial,
neurobiological and iatrogenic are suggested (Helmstaedter et al 2004; Kanner 2002).
The question as to whether depression in MTLE depends on the side (left/right) or site of
the lesion (mesial/lateral) is still under discussion. The data of Quiske et al. (2000)
however suggest that impairment of temporomesial limbic structures (mostly MTL
sclerosis) in contrast to focus of lateralisation appeared to be a predisposing factor for
depressed mood.
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The involvement of temporomesial limbic structures on more subtle impairments of social
and emotional cognition have not been widely studied. Recent studies suggest right MTLE
impairments in the ability to recognise fearful facial expressions (Benuzzi et al 2004;
Meletti et al 2003), whereas patients with early onset of seizures were the most severely
impaired. Subjects with lesions of the amygdala arising early in development
demonstrated deficits in advanced tests of reasoning about the mental states of others
such as detecting tactless or ironic comments or interpreting non-literal utterances (Shaw
et al 2004).
3.1.3 Neurological diagnostics of MTLE
Mesial temporal lobe epilepsy is diagnosed by the history of characteristic partial seizure
symptoms. The diagnosis is strongly supported by the electroencephalogram (EEG) and
by the neuroimaging of a lesion.
Interictal EEG may provide valuable information in lateralising the seizure focus in patients
with MTLE. The interictal EEG signature of this disorder are unilateral or bilaterally
independent mesial temporal spike and spike-and-wave discharges. A single awake scalp
EEG recording has a relatively low yield. The diagnosis is therefore confirmed by the
capture of a typical episode during an EEG or video-EEG with epileptiform activity over
one or both temporal regions (Devinsky 2004; Kilpatrick et al 2003).
Neuroimaging of anatomic lesions such as MTL sclerosis, are best revealed by high
resolution magnetic resonance imaging (MRI). Magnet Resonance Imaging for MTL
diagnostics relies on special MR-sequences, features suggestive of mesial temporal
sclerosis. They include: T1 weighted volumetric acquisition to allow quantitative
assessment of the hippocampal volume, T2 weighted acquisition and fluid attenuated
inversion recovery (FLAIR) to detect increased signal in the hippocampus. Most important
is that all coronal sequences shall be oriented orthogonal to the long axis of the
hippocampus (Knowlton 2004). The concordance of visually diagnosed hippocampal
atrophy and histologically verified cases is in experienced neuroradiologists around 80-
90% (Koepp et al 2005). Quantitative MRI measurements such as volumetry or the
definition of T2-relaxation times of the hippocampi are used to identify either subtle
unilateral or bilateral hippocampal sclerosis in certain patients. These techniques increase
the sensitivity to define hippocampal atrophy up to 90-95% (Koepp et al 2005).
Despite the use of high resolution images, MRI is normal in approximately 30% of patients
with MTLE (Siegel et al 2001). In these patients greater emphasis is placed on intracranial
EEG monitoring and functional imaging such as positron emission tomography (PET),
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single photon emission tomography (SPECT) and MR-spectroscopy (Knowlton 2004). 18F-
fluorodeoxyglucose (FDG)-PET typically measures interictal hypometabolism, reflecting
the preferential networks involved by ictal discharges and pathways of seizure spread
(Koepp et al 2005). Specific PET ligands methods with FDG and [11C]-flumazenil are used
to identify the functional integrity of the GABAergic inhibitory neurotransmitter system
(Koepp et al 2005). In studies, new PET ligands for opioid receptors, peripheral
benzodiazepine receptors, serotonergic, cholinergic and glutamatergic neurotransmission
have been tested in patients with MTLE and hippocampal sclerosis. They commonly give
redundant information of reduced ligand binding in areas with atrophy. Ligand PET is
unlikely to give better information than MRI in MTLE, but it could be used in the
assessment of patients who do not have signs of hippocampal sclerosis on MRI (Koepp et
al 2005). Ictal SPECT has developed into an established tool for aiding seizure
localisation. It shows increased blood flow in the seizure originating side such as in the
temporal lobe during complex-partial seizures in MTLE (Van Paesschen et al 2003). MR-
spectroscopy is sensitive to detect bilateral pathology. Altered metabolism caused by
neuronal loss or dysfunction and astrocytosis is indicated by ipsilateral reduction of N-
acetylaspartate and increased choline-containing compounds (Petroff et al 2003).
Intracranial monitoring includes the implantation of subdural and/or depth electrodes for a
period of days to weeks, to record seizure onset and to perform electrical stimulation
mapping. This provides valuable information on the spatiotemporal dynamics of large
neural assemblies that underlie pathology (Engel et al 2005). Morbidity from cortical
stimulation mapping comes from several sources: bleeding during placement or
withdrawal of electrodes, and local pathological changes corresponding to the length of
time the electrodes were implanted (Dubeau et al 2000).
3.1.4 Therapy of MTLE
Mesial temporal lobe epilepsy is treated by medications or, when the seizures are
refractory, by resective surgery. Half of patients respond to maximally tolerated doses of a
single AED (Kwan et al 2001). If adverse effects do not permit the use of therapeutic
doses, another monotherapy trial is usually tried (Kwan et al 2001). When seizures persist
despite high plasma levels, a trial of two AEDs is recommended. When monotherapy fails,
two AEDs will improve seizure control in more than one third of patients but will fully
control seizures in only 10% (Mattson et al 1985).
Medications can be divided into older medications (called first-generation anticonvulsants
such as phenytoin, carbamazepine, valproic acid or phenobarbital) and more recently
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developed medications (second-generation anticonvulsants such as oxcarbazepine,
vigabatrin, lamotrigine, zonisamide, gabapentin, tiagabine, topiramate and levetiracetam).
Effectiveness and side-effects of the ‚older‘ AEDs are well established. Most of the new
drugs are at least as effective as the ‘older’ AEDs but seem to be better tolerated.
Despite recent advances in the diagnosis and pharmacological treatment of localisation-
related epilepsy, seizures remain refractory to medical therapy in approximately 30% of
patients (Kwan et al 2000). For patients with pharmacoresistant seizures, epilepsy surgery
has become a serious treatment option. Standard surgical techniques are selective
amygdala-hippocampectomy and anterior temporal lobectomy with resection of the
hippocampal formation, the amygdala, and, depending on the surgical approach, lateral
temporal neocortex (Kim et al 2001).
Successful surgery is dependent on accurate localisation and lateralisation of the
epileptogenic zone. The preoperative evaluation involves a series of assessments and
investigations including detailed clinical history, interictal EEG, video-EEG monitoring,
MRI, neuropsychology and neuropsychiatric assessments (Kilpatrick et al 2003). The
findings of hippocampal sclerosis with the MRI techniques described above is highly
predictive of a good outcome from surgery (Gilliam et al 2000). Approximately 70% of
surgical candidates with MTLE become seizure free, and many others reach significantly
reduced seizure burden and improved quality of life (Helmstaedter 2004).
3.1.5 Neuropsychological diagnostics and evaluation of therapy in MTLE
Because of the importance of cognitive symptoms in MTLE, neuropsychologists have a
significant role in the assessment, treatment and rehabilitation of patients with MTLE.
Disturbances of cognitive function is one of the major influence on quality of life in
individuals with epilepsy (Trimble 1994) and may be more debilitating than the seizures
itself (Rausch et al 1997). Cognitive impairments result from various interacting factors
such as aetiology, age of onset, type of epilepsy, type of seizures, seizure frequency,
seizure duration, seizure severity, medication and duration of epilepsy (Jokeit et al 2004).
Neuropsychological diagnostics aim at determining the mental status including information
of individual’s cognitive strengths and weaknesses, to examine epilepsy- or lesion-related
cognitive impairments in order to yield diagnostic information that helps in lateralising and
localising the seizure focus, and finally to control for quality of treatment effects, namely
drug and surgery, on patients’ cognition (Baker et al 2004; Cull et al 1997). Each of these
specific roles require careful consideration with respect to the potential pitfalls they can
present.
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Cognitive side-effects of AEDs
All commonly used AEDs have some effects on cognitive functions, whereas individual
reactions to the cognitive effects of AEDs vary. Some patients experience problems even
with low serum levels, whereas others tolerate high levels with few or no complaints
(Devinsky 1995). In general, severity of cognitive side effects are considered to be mild to
moderate for most AEDs (Vermeulen et al 1995). But the impact can be amplified in
specific conditions and may become substantial in some patients when crucial functions
are involved or when functions are impaired that are already vulnerable such as memory
function in the elderly (Trimble 1987).
All of the older AEDs (i.e. valproic acid, carbamazepine or phenytoin) have ,absolute’
cognitive side effects, meaning that all of the investigated drugs have cognitive effects
when compared with no treatment in the same subjects (Aldenkamp et al 1987;
Aldenkamp et al 2003). All AEDs are reported to have adverse effects related to dosage
(Devinsky 1995) and are stronger for polypharmacy compared with monotherapy
(Aldenkamp et al 2003; Trimble 1987). The new AEDs might have less influence on
cognitive functions but there are only a few controlled studies available (Brunbech et al
2002).
The most prevalent of the cognitive side effects observed in an AED therapy are
impairments in attention, psychomotor and mental speed. Focal deteriorations are less
frequent and have been observed for memory in phenytoin (Aldenkamp 2001) and
carbamazepine (Meador et al 1993; Meador et al 1991) as well as for verbal skills in
topiramate (Aldenkamp et al 2003).
Regarding memory, the data are not finally conclusive, because recent studies lacked to
adequately control for seizures, interictal discharges and underlying brain disease
(Motamedi et al 2004). The adverse effects of AEDs on memory in patients with epilepsy
may be partly offset, in part, by reductions in seizures and interictal discharges. Treating
the seizures with AEDs may have positive effects on memory performance such as
observed in animal models. For example, studies in rats trained to run from electric shock
into a maze have shown better memory performance in normal rats treated with placebo
than in those treated with carbamazepine. On the other hand, epileptic rats treated with
carbamazepine functioned better compared with those who were not treated (Hawkins et
al 1985).
In addition, the effects of AEDs may interact with focal brain dysfunction. For example,
patients with MTLE were tested on a word list learning paradigm under conditions of high
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and low AED dosages (Durwen et al 1993). Memory performance on this verbal task
improved with AED dose reduction, but only for left MTLE patients and not for right MTLE
patients. The significant group differences in verbal memory for the left and right MTLE
groups under full AED dose disappeared with dose reduction.
Another factor affecting the results is mood. Mood alters subjective perception of memory,
but it is unclear what effect mood has on objective memory performance in epilepsy
patients and what interactive effects AEDs have on mood and memory (Motamedi et al
2004).
Cognitive side-effects of TLE surgery
Following TLE surgery, potential increases and selective decreases in cognitive functions
are likely to occur. Improvements following TL surgery are mostly related at least in part to
successful seizure control. When patients become permanently seizure-free, a
hierarchical release or recovery of extratemporal functions can be observed within the first
year of surgery which is followed by improvement of TL functions in the longer follow-up
(Helmstaedter et al 2002). On the other hand, patients undergoing TLE surgery are at risk
for memory deficits (Gleissner et al 2002).
Patients undergoing left TLE surgery are generally considered to be at greater risk for
postoperative memory decline than those undergoing right TLE surgery. In general, the
degree of memory decline depends upon both the functional status of the ipsilateral MTL
that will be included in the resection and on the functional status of the MTL contralateral
to surgery which will be relied upon for the formation of new memory.
Patients undergoing TL surgery are at risk for postoperative severe amnesia if the MTL
contralateral to the surgery is diseased and non-functional (Loring et al 2001a). The most
famous patient is H.M. (Scoville et al 1957), who suffered from a severe amnesic
syndrome after surgical resection of both temporal lobes. H.M. was unable to acquire any
new information for later recall, whereas memory performance of immediate memory and
skill learning remained intact (Corkin 2002). The very few publications on amnesic
patients since the publication of the patient H.M. indicate that amnesia can hardly be
predicted, or that it is a late rather than an acute consequence in patients who
decompensated after unilateral temporal lobectomy due to contralateral damage after
status epilepticus, severe seizures, or head injury (Dietl et al 2004; Oxbury et al 1997). A
recent review shows two of seven cases in whom asymmetry in memory performance
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might have been predictive for amnesia but this study does not show how often the same
pattern is seen without the severe consequence of amnesia (Kapur et al 2003).
To summarise, postoperative losses following TL surgery can be reduced when surgery is
restricted to tissues not any more involved in function. Additionally, a better outcome is
observed with greater cerebral plasticity and greater capacities for compensation.
Regarding reserve capacity, the major determinants of a better cognitive outcome after TL
surgery are surgeries within the non-language-dominant hemisphere, younger age at the
time of surgery, better baseline performance, better intellectual capacity, and more
successful seizure control (Helmstaedter 2004).
The impact of neuropsychological diagnostics is therefore to anticipate a potential risk for
postoperative memory dysfunction. Besides the traditional neuropsychological
examination, the intracarotid amobarbital test (IAT) and increasingly also fMRI is used to
define presurgically the eloquent cortex. The method of fMRI will be discussed in detail in
the next chapter. The IAT procedure is currently the most common and reliable method
used to assess language and memory function (Loring et al 2001b). The IAT
anaesthetises an entire hemisphere in order to test the other hemisphere for language
and memory function, including verbal and visual encoding or retrieval efficiency. It is an
invasive procedure, difficult to repeat and is, unfortunately, associated with rare but
significant complications.
Beyond the function of MTL structures in memory, the amygdala is one of the key
structures involved in emotional processing. Patients undergoing TL surgery may
therefore be at risk for impairments in emotional processing, including social behaviour
and specific functions of social and emotional cognition (Adolphs et al 2001; Anderson et
al 2000; Brierley et al 2004; Hermann 2002). However, the question of whether certain
impairments following TL surgery are related to resected parenchyma of the amygdala is
a matter of controversy.
3.2 Functional MRI in MTLE
Functional MRI plays an increasing role in the diagnostics of MTLE. Moreover, the use of
fMRI in presurgical evaluation of patients with epilepsy is probably the most important
clinical application (Vingerhoets et al 2004).
Functional MRI relies on blood oxygen level dependent contrasts to detect cortical areas
of neuronal activation. In epilepsy diagnostics it is mainly used to map language and
memory functions. It also contributes to the detection of seizure lateralisation, because
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memory functions are subserved by the same brain regions that typically harbour the
seizure focus itself in TLE (Detre 2004). Functional MRI is not yet established in other
areas of neuropsychological interest, e.g. effects of AEDs on cognition.
Generally, the use of fMRI in a clinical setting presents challenges beyond those
encountered in studies with healthy volunteers. Functional MRI relies on very small
regional changes. In single-case designs such as in a clinical setting and especially within
the MTL, the signal changes are even smaller. The main demand is therefore to design
fMRI applications which yield strong, robust and meaningful results on single-subject
level.
3.2.1 General considerations on the use of fMRI in MTLE
Before this report will turn to the topic of the clinical application of fMRI in MTLE, a short
presentation of the fMRI-technique and specific areas for its clinical use will be provided.
3.2.1.1 Functional MRI techniques and the neural basis of the BOLD signal
Functional MRI is not a direct measure of neural activity. Instead, signal intensity
alterations are caused by stimulus-induced local changes in blood oxygenation, called the
blood-oxygen-level-dependent (BOLD)-contrast. It is based on the differing magnetic
properties of oxygenated (diamagnetic) and deoxygenated (paramagnetic) blood. These
differences in magnetic susceptibility lead to small, but detectable changes in
susceptibility-weighted MR image intensity.
A typical BOLD response consists of a 1-5% change in regional image intensity which
develops over a 3-8s period after task initiation, typically with an initial peak or overshoot,
a somewhat lower plateau for sustained tasks, and often an undershoot of the baseline
after task completion (figure 1, white line). The peak latency of several seconds
represents a major limiting factor in the temporal resolution of functional imaging methods
(Hennig et al 2003).
The relationship between neuronal activity and fMRI signal is quite complicated, involving
multiple neurophysiological mechanisms such as interaction between blood flow, blood
volume and haemoglobin oxygenation. Functional BOLD contrast is obtained because the
iron, present in haemoglobin, becomes paramagnetic only when it is deoxygenated,
producing a local susceptibility increase (Ogawa et al 1993). With regional brain
activation, decreases in regional deoxyhaemoglobin occurs which has been attributed to
increases in cerebral blood flow (CBF) and glucose consumption that exceed increases in
oxygen consumption. The precise basis for this mismatch is uncertain, but recent studies
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have shed light onto both the cellular mechanism of metabolic and vascular processes
that are relevant to functional imaging and the neuropyhsiological underpinnings of the
fMRI signal.
The basic principle is that neuronal activity is closely connected to changes in blood flow
and oxygenation and energy metabolism. Recent data suggests that both, the vascular
and the metabolic response to neuronal activity are mediated by glutamatergic
neurotransmission (Attwell et al 2002; Magistretti et al 1999). Glutamate is the main
excitatory neurotransmitter in the brain and is released following neuronal activation. After
it is released, glutamate needs to be removed promptly from the synapse and this occurs
by uptake into an adjacent non-neuronal cell - an astrocyte. There, it is converted to
glutamine before it can be returned to the neuron where it is recycled. The neurometabolic
coupling to glutamatergic neural activity is based on the fact that all steps from the release
of glutamate to its transformation as well as its actions on postsynaptic receptors require
energy. This energy demand is preferentially met by the glycolytical transformation of
glucose into lactate in astrocytes and by oxidative phosphorylation of glucose and lactate
in the neuron. Both pathways contribute significantly to glucose consumption (Magistretti
et al 1999).
Neurovascular coupling to glutamatergic neural activity is explained by the release of nitric
oxide and prostaglandin from neurons or astrocytes upon a glutamate invoked intracellular
rise in calcium. Nitric oxide and prostaglandin are potent vasodilator agents and thus
leading to an increase in blood flow during activation. Although, neurometabolic and
neurovascular coupling are both mediated by glutamatergic transmission, the increase in
blood flow and energy utilisation can be dissociated and should be considered to the
results of processes operating in parallel.
The neurophysiological basis that underlies the BOLD signal has been investigated by
simultaneously recording neuronal activity and fMRI. A number of studies have
demonstrated that the haemodynamic response reflects directly an increase in neural
activity elicited by a stimulus (Logothetis et al 2001; Ogawa et al 2000; Rees et al 2000).
BOLD responses and neural responses even seem to have a linear relationship for
stimulus presentations of short duration. Logothetis and co-workers (2001) simultaneously
recorded in their experiments electrophysiological signals and fMRI responses in
anaesthetised monkeys that were viewing checkerboard patterns. The authors have
shown that the BOLD contrast directly reflects neural responses elicited by a stimulus and
that BOLD signal and neural activity are linearly correlated for short stimulus presentation
duration.
Theoretical background
17
3.2.1.2 The experimental design
During an fMRI scan, a task is presented to the subject while lying in the scanner. It
requires the subject to perform specific acts and thereby induces series and complexes of
neuronal events in a controlled manner. Task-specific BOLD signal changes are not
directly quantifiable in physiological units. They are typically measured relative to a
baseline condition and expressed as a percentage signal change or as a statistical signi-
ficance level based on a particular statistical model.
The traditional approach of conducting an fMRI study is the so called block design (figure
1). Block designs encompass alternating epochs of task and control conditions. This
approach maximises sensitivity, because large signal changes are sustained, and also
minimises dependence on an accurate estimate of the activation-flow coupling response.
Figure 1: Outline of stimulus presentation and response for a simple functional magnetic resonance
imaging (fMRI) experiment in primary visual cortex. The boxcar fMRI stimulus presentation
paradigm consists of alternating periods of stimulation (on-state, red) and rest (off-state, blue).
A correlation waveform (black) is used for analysis. It is delayed slightly with respect to the
stimulus presentation in order to allow for the lag between neuronal activity and the
haemodynamic response. The white line represents an example of raw data set.
It is assumed that subtraction of images acquired during an ‘on-state’ and an ‘off-state’
can be used to isolate activation responses. For example, comparison of a visual
stimulation (on state or active state) to darkness (off-state or control state) activates
primary visual areas.
Many brain functions, such as memory cannot be isolated that way, because they are
coupled to other functions (Friston et al 1996), including attention, language or executive
functions. More complex sets of tasks are required, involving multiple task-demands. The
activity is then averaged over different cognitive processes that can occur during a
specific task (Maguire et al 2003).
Because the time course of the haemodynamic response measured with the BOLD
method is slow relative to the primary neuronal activation event, the rates of changes
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between cognitive states in a paradigm must in most cases be kept slow relative to the
expected time course of the haemodynamic response. The optimal duration of an epoch is
determined by the time course of the haemodynamic response and typically lasts from
16s to 30s.
Another experimental approach is the so called event-related fMRI experiment. In contrast
to the block-design, it allows to sort and to average the brain activity of events based on
participants’ responses such as whether a stimulus was recognised or not in a memory
task. However, the signal detection power of event-related fMRI is much lower than that in
a block design (Liu et al 2004). Even more, the MTL is a non-optimal target for event-
related fMRI, because the magnitude of the signal is much lower (less than 1% (Powell et
al 2004)) than in primary sensory areas. Thus, event-related fMRI is a valuable tool for the
measurement of perceptual functions, in which a high number of stimuli can be presented
and the loss of signal detection power can be afforded, in contrast to MTL-related
structures and single-case studies such as in clinical measurements, in which these
limitations can lead to serious disadvantages.
The challenge to design fMRI-paradigms in a clinical setting is to develop tasks which on
the one hand activate reliably and robustly the target structure and which have on the
other hand a low cognitive demand, so that patients can do them. Nevertheless, they have
to be interesting, so that patients cooperate well. Scans in which there is little or no
activation might suggest poor cooperation, sleep or an inability to do the task.
3.2.1.3 The difficulty of imaging the MTL in clinical studies
The signal within the MTL is low. The TL is most confronted with high susceptibility arte-
facts caused by inhomogenities due to the differing magnetic properties of bone, tissue
and air in its vicinity (Powell et al 2004). The TL is therefore especially likely to suffer from
geometric distortions or loss of BOLD signal (Jezzard et al 1999). The observation that
multisubject group maps tend to demonstrate much more robust activation in the
hippocampal head than individual subject studies (Killgore et al 1999) provides further
evidence suggesting that detecting this activation is limited primarily by sensitivity.
However, averages of activation patterns are not necessarily representative for each
individual subject especially in clinical studies and therefore meaningful data at the single-
subject level is required.
On the technical side, a number of recent developments in MRI hardware might greatly
increase the sensitivity of fMRI for MTL activation. Recent efforts to overcome the
problems include techniques such as z-shimming (Rabin et al 2004) or ultra-thin slices
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(Constable et al 1993) to minimise susceptibility artefacts. Another approach is the use of
higher field strength magnets such as 3T or even 7T. The use of higher magnetic fields
improves contrast and elevates sensitivity to capillary level blood flow changes coupled
with neuronal activity (Hennig et al 2003; Krasnow et al 2003). A problem is that higher
fields require faster ‘gradient switching’ (i.e. the additional magnets that are switched as
part of the data acquisition scheme), resulting in higher levels of electromagnetic power
and subsequently in the risk of inducing nerve stimulation. Unfortunately, high magnetic
fields also magnify some of the problems inherent in MRI such as field distortions and
motion artefacts (Hennig et al 2003). One of the main concerns in clinical use of fMRI are
the artefacts and noise from motion, since patient movements of the order of a few
millimetres during the imaging can severely deteriorate the quality of the data and induce
severe artefacts (Koepp et al 2005). Clinical fMRI-studies on higher field strength such as
3T is therefore difficult. It is not surprising that only one study is available demonstrating
the possibility of imaging epilepsy patients at 3T (Szaflarski et al 2004). As the study had
a small sample size (no more than six patients), the data are preliminary and the utility of
high field fMRI in a clinical context needs to be investigated in a larger population.
However, 1.5T is the norm for clinical scanners, at least within the next years. Therefore
other approaches than higher field strengths have to be discussed to increase the signal-
to-noise ratio (SNR). Unrelated to the MTL, several attempts have recently been
undertaken to enhance BOLD signal intensity with the application of pharmacological
substrates. The studies are related to primary sensory and motor areas, but it might be
hypothesised that the MTL could profit by a pharmacologically induced contrast booster,
too. The application of methylxanthines such as theophylline or caffeine has been
recommended as a BOLD contrast booster for studies confronted with low SNR (Laurienti
et al 2002; Mulderink et al 2002). However, the studies presented above used group-
results which are not necessarily representative for clinical applications. In addition, the
research of caffeine as a BOLD contrast booster is restricted to primary sensory and
motor modalities (Laurienti et al 2002; Mulderink et al 2002), whereas the effects on the
MTL have not yet been investigated. The first study of the present thesis investigates
therefore whether caffeine is an effective BOLD contrast booster within MTL for clinical
studies.
3.2.1.4 The importance of reproducibility for clinical studies
Because of the low SNR in MTL, and especially in single-case studies, it is indispensable
to validate clinical fMRI paradigms in terms of its retest-reproducibility. The requirements
to validate the reliability of activation patterns is highest in presurgical investigations,
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because the results have a clear and significant impact on patients’ health. In the context
of presurgical mapping for example, it has to be proven that single-session results are
valid and it must be demonstrated that the patterns of brain activation developing in
response to the same task are repeatable between imaging sessions.
In spite its importance, there are only few studies concerned with the reproducibility of
single-session fMRI protocols. Additionally, the studies might be biased because of
underrepresentation of negative findings in the peer reviewed literature. However, in the
available studies, a relatively high consistency of activation pattern over time has been
reported, mainly in motor or visual areas (Rombouts et al 1998; Yetkin et al 1996), but
also for cognitive tasks such as working memory (Wei et al 2004), visual encoding
(Machielsen et al 2000) and episodic retrieval (Miller et al 2002). Regarding memory-
related structures Miller and co-workers (2002) observed highly variable activation
patterns from individual to individual. Despite large variations from subject to subject,
those individual patterns of activation were reliable over time. The authors suggest that
individuals may have been using very different strategies and cognitive processes during
the task, and those differences were reflected by different patterns of brain activations.
Some clinical questions demand the possibility to evaluate the quantitative reproducibility
of the BOLD response in serial investigations. Reproducibility of activation magnitude as a
quantitative approach is desired to investigate any changes within a given structure and
reports the reproducibility in terms of the magnitude and spatial extent of activation. This
is difficult to obtain, because there are a lot of factors affecting the BOLD response such
as technical (instability of the scanner, drifts of the man magnetic field during the scanning
session), physiological (e.g. hyperventilation) or psychological phenomena (e.g. attention
effort (Specht et al 2003)). The evaluation of quantitative reproducibility is far less used in
clinical settings than the reproducibility of activation patterns.
Unfortunately, quantitative reproducibility seems to be poor on intra-individual levels
(McGonigle et al 2000; Miki et al 2000; Moser et al 1996; Waldvogel et al 2000). At least,
lower variability within subjects than between subjects has been reported (Aguirre et al
1998; Wei et al 2004). But the reported studies rely mainly on primary visual and motor
areas, whereas cognitive tasks are scarcely investigated (Machielsen et al 2000). It is
therefore questionable whether cognitive fMRI tasks lead to stable activations. Since
Specht and co-workers (2003) reported increased reliability in attended compared to
unattended visual tasks, it might be suggested that cognitive tasks with higher complexity
and more task demands reveal higher retest-reliability.
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3.2.2 Functional MRI in the evaluation of cognitive side-effects of AEDs
To date, neuropsychological testing has been the major method of objectively examining
cognitive functions related to the use of AEDs, but methodological inaccuracies in clinical
studies may obscure the effects of AEDs on cognition. As already discussed, it is difficult
to control for interactions of AEDs with seizures, interictal discharges, underlying brain
disease and mood. Therefore, innovative methods such as fMRI may help to avoid some
of the confounds.
Besides the field of epilepsy, fMRI has widely been administered to investigate drug
effects. Effects on the magnitude or extent of the percent BOLD signal change have been
observed in both directions such as caffeine boosted the BOLD signal (Mulderink et al
2002) while ethanol had inhibiting effects (Levin et al 1998; Seifritz et al 2000). Common
paradigms are visual and motor tasks. Studies regarding memory are few, such as
Sperling and co-workers (2002) who observed a correlation between scopolamine and
lorazepam-induced memory deficits and reduced activation in the hippocampus and
fusiform gyrus.
Regarding study designs, only few studies point out significant intra-individual drug
induced effects (Loubinoux et al 2002; Martin et al 2000; Sell et al 1997). Exactly single-
case designs would be crucial in the investigation of drug effects in epilepsy patients.
Methodologically, it has to be considered that few studies (e.g. Loubinoux et al 2002; Rao
et al 2000; Seifritz et al 2000) used well defined conditions and provided reliability
estimations. The latter are inevitable because the measurements are administered under
different drug-conditions and the BOLD response is already variable over repeated scans
(Machielsen et al 2000; McGonigle et al 2000; Waldvogel et al 2000).
Although fMRI has increasingly been applied in neuropharmacological studies dealing
with drug effects on the brain (Honey et al 2004; Leslie et al 2000), investigations about
the effects of AEDs on the BOLD response are rare. There are only two studies dealing
with this topic. Bell and co-workers (2005) investigated the effect of dextroamphetamine
on the brain in valproic acid treated subjects. The pre-treatment with valproic acid led to
decreased signal-changes in a working memory task. Another study found a correlation
between carbamazepine serum level and decrease in the memory induced activation of
MTL structures (Jokeit et al 2001b). Memory-related MTL activation was induced by the
Roland’s Hometown Walking Task (Jokeit et al 2001c) which encompasses mental
navigation and recall of landmarks of a familiar visuospatial environment. The observed
decrease is consistent with reports of behavioural memory decline on high doses of
carbamazepine (Meador et al 1993) and with reduced cerebral glucose metabolism as
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shown by glucose PET in epilepsy patients receiving carbamazepine (Theodore 1988).
However, it is necessary to replicate this result in longitudinal studies, ideally covering
initiation, chronic administration and withdrawal of AED.
3.2.3 Functional MRI in presurgical MTLE diagnostics
Presurgical evaluation of MTLE patients using fMRI includes the mapping of language and
memory. With the introduction of fMRI it was hoped that this new technique might
supersede invasive procedures such as the IAT or cortical stimulation. In contrast to such
invasive tests, fMRI is less risky, repeatable and more widely available. But, before non-
invasive fMRI can replace them, it is necessary to show that first fMRI can be used in the
majority of patients otherwise undergoing invasive procedures that secondly fMRI
acquisition and assessment are easy and reproducible and third that fMRI provides typical
and atypical results in large numbers of individual cases in concordance with a standard in
presurgical diagnostics (e.g. the IAT) or postoperative outcome (Hammeke et al 2000).
Language
Within presurgical diagnostics of MTLE patients, language lateralisation is the most widely
studied clinical application of fMRI. Tasks are related to semantic judgement, verbal
fluency, story comprehension and combined tasks (Detre 2004). By the use of
comprehensively designed series of language tasks, fMRI has been able to reliably
identify the language-dominant hemisphere, to provide estimates of localisation of
activated networks and to identify eloquent language regions in the vicinity of the surgical
target, thus reducing the risk of serious postoperative complications (Matthews et al
2003).
The external validation with presurgical invasive methods has best been shown for
language-lateralisation, where a high concordance of 90% between fMRI and IAT was
found, with atypical lateralisation predicting postsurgical deficits. In left-sided TLE, the rate
of false categorisation by fMRI was not higher than 3%, whereas the rate of false
categorisation increased to 25% in left-sided extratemporal epilepsy (Binder et al 1996;
Sabsevitz et al 2003; Woermann et al 2003).
The information about language dominance is also important for subsequent evaluation of
memory functions, because it can significantly influence its laterality. For instance, in
patients who have atypical language dominance due to early epileptogenic lesions in the
left hemisphere, re-allocation of language and verbal memory to the right hemisphere can
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cause deficits of functions that are originally lateralised to the right hemisphere (Akanuma
et al 2003). The presence of atypical language dominance is higher in epileptic patients
than in the general population. 33% of patients with left-sided intractable temporal-lobe
epilepsy show atypical language representation with bilateral or right hemisphere
language-related lateralisation (Adcock et al 2003).
Memory
Results from memory-related fMRI measurements are of use in determining the risks of
amnesic complications from temporal surgery. Additionally, memory-activation patterns
observed with fMRI also contribute to seizure lateralisation, because memory functions
are subserved by the same brain regions, where the seizures typically arise in TLE (Detre
2004).
The utility of fMRI for lateralising memory function in presurgical testing of medically
refractory MTLE patients has been shown in recent studies by using episodic encoding
memory paradigm with complex visual scenes (Detre et al 1998; Stern et al 1996) or
multimodal stimuli (Golby et al 2002; Kelley et al 1998) or by retrieval from longterm-
memory (Jokeit et al 2001c). The principle of memory fMRI-paradigms bases on the aim
to bilaterally activate the MTL during memory tasks, because fMRI is not capable of
assessing the unilateral capacity of the MTL structures thought to be critical in forming
new explicit memory. Accordingly, the failure to activate the left or right MTL reflects
impaired function. Jokeit and co-workers (2001c) have shown that their fMRI memory
paradigm, the Roland’s Hometown Walk, effectively lateralises the epileptic temporal lobe
by activation of the parahippocampal gyri. The advantage of this paradigm is the retrieval
from longterm-memory which is very close to the patients’ everyday practical use of their
memory.
Compared to language-lateralisation, less meaningful data regarding external validation of
memory-related fMRI with IAT are available. The studies rely on small sample sizes,
mostly with left-sided MTLE cases (Detre et al 1998; Golby et al 2001; Rabin et al 2004).
Nevertheless, the results are promising as far as positive correlations were found between
presurgical activation asymmetry ratio within MTL and hemispheric memory dominance
found with IAT (Detre et al 1998; Golby et al 2001; Rabin et al 2004). The Roland’s
Hometown Walking Task finally, correctly lateralised the side of seizure onset in 90% of
30 patients with unilateral MTLE (Jokeit et al 2001c).
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It has therefore to be mentioned that although fMRI of memory-lateralisation is far from
widely replacing the invasive IAT, it even now contributes to seizure lateralisation and
determinates the risks of amnesic complications from temporal lobectomy (Detre 2004).
Regarding the latter, recent studies suggest a predictive value of fMRI for postsurgical
memory outcome (Koepp et al 2005). Rabin and co-workers (2004) used a complex visual
scene-encoding task to show a relation between MTL activation asymmetry ratios and
postsurgical memory outcome; increased activation ipsilateral to the seizure focus was
related to greater memory decline. In an event-related linguistic encoding fMRI study in
patients with left hippocampal sclerosis, greater activity in the left hippocampus compared
with the right hippocampus predicted the extent of verbal memory decline after left
anterior temporal lobectomy (Richardson et al 2004). Using the Roland’s Hometown
Walking Task, a recent study (Janszky et al 2005) showed that this task can predict
postoperative memory decline in MTLE. Memory-fMRI findings correlated with individual
memory decline measured by a non-verbal memory test after right-sided anterior temporal
lobectomy.
The combination of presurgical information including memory-related fMRI results,
structural MRI with information about the hippocampal volume and neuropsychological
assessment improve the accuracy of prognosis for cognition made before unilateral
anterior temporal-lobe resection. Surgical procedures could be modified in those patients
with a high risk of cognitive impairment and the preoperative patient counselling could be
improved (Koepp et al 2005).
Other functions related to MTL
Besides the presurgical diagnostics of memory-related MTL structures and in contrast to
the invasive IAT, fMRI would provide the possibility of mapping additional features such as
the amygdala. In recent presurgical fMRI-protocols of MTL structures, the amygdala has
rarely been evaluated. Imaging the amygdala presurgically might allow one to evaluate
the possible clinical implications for amygdala-related functions residing within the to be
resected tissue and may help to identify candidates who are at risk of emotional and
social impairment following TL surgery.
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4 General questions
One of the major concerns of neuropsychological diagnostics of MTLE is to evaluate and
to prevent negative treatment effects on patients’ cognitive profiles. Both, pharmaco-
therapy and epilepsy surgery may have substantial influence on cognition. The fact that
cognitive disturbances are one of the major influence to impair quality of life in individuals
with epilepsy (Trimble 1994) makes the investigation of such treatment effects necessary.
In addition to the classical neuropsychological examination, fMRI is increasingly being
applied in clinical diagnostics. The most important and the most advanced clinical
application of functional MRI is found in presurgical diagnostics, whereas investigations of
pharmacological treatment effects are few and rely on group and cross-sectional studies.
The studies reported here address three selected topics in the field of clinical fMRI within
the MTL. The first study approaches a more technical question of fMRI within MTL,
namely whether certain substances are able to increase the low BOLD contrast in this
region which is confronted with low SNR. The second and third study take up recent
advances of fMRI in pharmacological fMRI and in presurgical diagnostics.
In all three studies we used the Roland’s Hometown Walking Task (Jokeit et al 2001b) to
activate the MTL. This task uses a block-design. During the activation block, the subjects
have to mentally navigate through their hometown and to retrieve spatio-temporal
information from long-term memory. The baseline condition consists of covertly counting
odd numbers, starting with 21. This paradigm has been shown in many studies to reliably
activate the MTL bilaterally on a single-subject level, including patients with MTLE,
patients with low formal IQ, children, older subjects and subjects from other cultures (Avila
et al 2004; Janszky et al 2005; Janszky et al 2004; Jokeit et al 2001b; Jokeit et al 2001c).
The advantage of this paradigm is its practicability, reliability and its close relation to
every-day memory demands. A disadvantage of the paradigm is that there is no control of
memory performance. We therefore added a behavioural control task and modified the
task as follows: In preparation for fMRI acquisition, the subjects had to fill out a familiarity
questionnaire of the landmarks of their hometown. Only landmarks with high familiarity
were included in the individual hometown walks. Blocks with approximate ways (including
similar type and similar number of landmarks) of approximately 300 meters were included.
To control for memory performance during the fMRI-task, the subject was asked to write
down the starting and endpoint of the 10 walks after each fMRI-session.
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4.1 First study: Caffeine study
4.1.1 Aim of the first study
Functional MRI bases on very small regional signal intensity changes. One of the major
difficulty in the application of fMRI in a clinical context is therefore to yield meaningful
results on single-subject level. The use of a contrast booster would simplify fMRI
measurements in clinical contexts, especially within the MTL, where the SNR is genuinely
low. Recently, the application of caffeine has been recommended as a BOLD contrast
booster for studies confronted with low SNR. However, the reported studies were
restricted to primary sensory and motor modalities (Laurienti et al 2002; Mulderink et al
2002).
This study was aimed at evaluating caffeine as a contrast booster for fMRI-investigations
in a clinical context. We intended therefore to reproduce the reported group-results of an
increased percent BOLD signal change following caffeine intake in a single case, placebo
controlled, repeated fMRI study within three distinct domains, namely, within primary
visual and motor area and within memory-related MTL-structures.
4.1.2 General questions
(1) Are the reported group results of caffeine as a BOLD contrast booster within primary
visual and primary motor area reproducible on the single-subject level?
(2) Does caffeine enhance the BOLD contrast also within the MTL and are these en-
hancing effects observable on the single-subject level?
4.1.3 Hypotheses
Recently, Mulderink and co-workers (2002) suggested the use of caffeine as a BOLD con-
trast booster for studies confronted with a low SNR. The authors reported a considerable
overall increase of 26-37% in the BOLD-contrast in a visual (V1) and a motor (M1) area
during the performance of a visually cued motor task after application of 200mg caffeine.
In addition, Laurienti et al. (2002) found an increased BOLD signal in the visual cortex
induced by visual stimulation following 250mg caffeine intake in high caffeine users.
These studies referred to group designs without administration of both placebo and
caffeine conditions (Mulderink et al 2002) or  pre- and post caffeine conditions in one
single subject (Laurienti et al 2002). In contrast, we chose an extended study design with
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each person acting as their own control in four baseline, two placebo and two caffeine
measurements.
(1) We hypothesise that the application of caffeine is efficient to boost the BOLD
contrast on a single-subject level.
Although highly desired, there is no research into the use of BOLD contrast boosters such
as caffeine within the MTL. It might be expected that caffeine enhances the BOLD signal
within the MTL as it was observed within primary visual and motor areas. Caffeine is a
non-selective adenosine receptor antagonist and blocks neurovascular receptors with a
slightly higher affinity than that of neural receptors (Dunwiddie et al 2001). Blockade of
vascular adenosine receptors produces vasoconstriction and decreases resting cerebral
perfusion (Dunwiddie et al 2001). This decrease in baseline cerebral perfusion might
produce an enhanced BOLD signal intensity (Dager et al 2000; Mulderink et al 2002). It
might be suggested that this mechanism is not restricted to special regions such as
primary visual and primary motor areas and that therefore an enhanced BOLD signal
following caffeine intake might be observed within the MTL, too.
(2) We hypothesise that caffeine enhances the BOLD contrast within the MTL and
that enhancing effects can be observed on a single-subject level.
4.2 Second study: Reproducibility of serial fMRI scans
within the MTL
4.2.1 Aim of the second study
Antiepileptic drugs may have mild to moderate cognitive side effects, but their impact may
be substantial when critical functions such as memory in MTLE patients, are involved
(Aldenkamp 2001; Kwan et al 2001). Therefore, the cognitive side-effects of AEDs on
memory-related MTL structures needs to be evaluated.
To date, neuropsychological testing has been the major method of objectively examining
cognitive side-effects related to the use of AEDs. However, it allows no control for
interactions of AEDs with seizures, interictal discharges, underlying brain disease and
mood. Innovative methods such as fMRI may help to overcome some of the limits of the
classical neuropsychological examination.
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Besides the field of epilepsy, fMRI has increasingly been applied in neuropharmacological
studies dealing with drug effects on the brain (Honey et al 2004; Leslie et al 2000). But
recent studies mainly addressed short-acting drug effects, cross-sectional designs and
group analyses. AEDs on the other hand are long-lasting treatments which require
longitudinal study designs. Because of the heterogeneity of epilepsy patients,
investigations on a single-subject level would be desirable.
The present study was therefore aimed at investigating the longterm-reproducibility of
serial fMRI scans within the MTL. We used the Roland’s Hometown Walking Task (Jokeit
et al 2001c) to activate memory-related MTL structures. We investigated whether this task
is robust enough to investigate the cognitive side-effects of AEDs in future studies. It was
aimed at describing the variability of fMRI results with respect to number of significantly
activated voxels and percent BOLD signal change on single-subject and on group level.
The knowledge about the amount of variability is indispensable to distinguish between the
variations inherent in the examination method and the treatment induced changes in
subjects’ brain activation in future studies.
4.2.2 General questions
(1) How variable are the results (number of significantly activated voxels and percent
BOLD signal change) of serial fMRI scans elicited by the Roland’s Hometown Walking
Task within the MTL in single-subject and in group analyses?
(2) Does the observed variability of the fMRI-results (number of significantly activated
voxels and percent BOLD signal change) allow future investigations of treatment
effects of AEDs on the MTL?
4.2.3 Explorations
The longterm-reproducibility of fMRI results with more than three scans has rarely been
investigated. On group analyses, Wei and co-workers (2004) recently reported small
longitudinal variability in a working-memory task over nine serial fMRI-scans. The
intersession variability of serial scans on the single-subject level has been observed in two
studies (McGonigle et al 2000; Waldvogel et al 2000). Both found high intra-individual
variability. There is no single study reporting quantitative retest-reproducibility of serial
fMRI scans.
(1) We will explore the magnitude of variability of MTL activations induced by the
Roland’s Hometown Walking Task over serial scans in single-subjects and in
group analyses.
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The knowledge about the magnitude of variability is indispensable to distinguish between
the variations inherent in the examination method and the changes in subject’s brain
activation by treatment effects in future studies. Only two pharmacological fMRI studies
investigated drug-effects within the MTL. Both, the anticholinergic drugs lorazepam and
scopolamine (Sperling et al 2002) and the antiepileptic drug carbamazepine (Jokeit et al
2001b) decreased the BOLD signal within the MTL. Compared to a placebo-condition,
lorazepam and scopolamine decreased the number of significantly activated voxels within
the hippocampus by approximately 40-60% and the percent BOLD signal change by
approximately 50-60%. Including only high doses of carbamazepine (serum levels of more
than 7 mg/l), the decrease of significantly activated voxels within the MTL was around
50%. Whenever side-effects of a pharmacological agent shall be detected with fMRI, the
amount of variability of the used method has to be below those anticipated drug effects.
(2) We will explore whether the magnitude of the observed variability will allow
future investigations of treatment effects of AEDs on the MTL.
4.3 Third study: Amygdala fMRI in MTLE
4.3.1 Aim of the third study
Functional MRI is an important method in presurgical diagnostics of patients with
refractory MTLE. In the past, fMRI diagnostics of MTLE concentrated on the evaluation of
memory-related structures including the hippocampus and parahippocampus, whereas
the amygdala was rarely evaluated. Jokeit and co-workers (2001c) have shown earlier
that the Roland‘s Hometown Walking task effectively lateralises the side of MTLE by
memory-related activation of the parahippocampal gyri. Furthermore, the paradigm has
been validated with the intracarotid amobarbital test (Woermann et al 2003) and the
postsurgical outcome (Janszky et al 2005).
The present study is aimed at providing an fMRI paradigm to investigate the amygdala.
We developed an fMRI paradigm that includes the visual presentation of sequences from
thriller and horror movies showing actors portraying fearful faces. With the use of two
distinctive fMRI-paradigms, mapping both the amygdala and the parahippocampus, it is
aimed at improving the reliability of MTL diagnostics in MTLE patients.
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4.3.2 General questions
(1) Is it feasible to image the amygdala reliably in individual cases, including epilepsy
patients and healthy volunteers?
(2) Does the paradigm used fulfil the diagnostical prerequisite of replicable activation
within the amygdala?
(3) Does the use of two distinctive MTL paradigms improve the reliability of MTL
diagnostics?
4.3.3 Hypotheses and explorations
In recent neuroimaging studies the amygdala showed the largest and most consistent
activation when individuals viewed negative, especially fearful, facial expressions (Zald
2003), even when unattended (Critchley et al 2000; Gorno-Tempini et al 2001; Vuilleumier
et al 2001). The comparison of static versus dynamic facial presentations in an fMRI
paradigm revealed stronger amygdala activation for dynamic presentations (LaBar et al
2003). Further, the amygdala participates in biological motion such as eye gaze and body
movement perception, even when the stimuli have no apparent emotional content (Bonda
et al 1996; Kawashima et al 1999).
(1) We hypothesise that the use of an animated fearful face paradigm leads to
strong and reliable amygdala-activations in single subjects including epilepsy
patients and healthy volunteers.
In recent years, an increasing number of studies using fMRI addresses the activation of
the amygdala. The studies mainly addressed group results (Zald 2003) and did not refer
to clinical contexts. Up to now, the within-subject reproducibility with regard to MTL
structures has not yet been evaluated. From group studies it is known that the amygdala
demonstrates rapid habituation (Zald 2003), but this pattern is referred to within-session
habituation (Breiter et al 1996; Phillips et al 2001; Thomas et al 2001; Wright et al 2001;
Wright et al 2003) and is not transferable to between-session measurements, especially
not on a single-case level. However, the use of a paradigm in a clinical context demands
that the detected activations are reproducible on an intrasubject level.
(2) We will explore whether the paradigm induces reproducible activations within
the amygdala.
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To date, fMRI of memory-lateralisation is far from widely replacing the invasive IAT. With
recent procedures, the reliability of lateralisation was not higher than around 90% (Killgore
et al 1999). Therefore, an increase of the reliability of MTL diagnostics in MTLE patients is
highly desirable. We assume, that the use of two distinctive MTL paradigms increases the
reliability of MTL diagnostics. This requires that the fearful face task lateralises
hemispheric asymmetries in epilepsy patients and that this paradigm reveals additional
information by observing dissociations between amygdala and parahippocampal
activation.
(3) We will explore whether the use of two distinctive MTL paradigms improves the
reliability of MTL diagnostics.
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5 Experimental studies
5.1 First study: On the use of caffeine as a contrast
booster for BOLD fMRI studies
5.1.1 Introduction
Functional BOLD imaging relies on very small regional changes in the concentration of
deoxyhaemoglobin. The mean change in signal intensity in a typical multi-subject fMRI
study is ideally somewhere between 1-5%, but in single-case studies, for example in a
clinical setting, often even less. Therefore, a considerable amount of research effort has
been undertaken to enhance BOLD signal intensity and several pharmacological
substrates have been tested for their impact on the BOLD-signal (Li et al 2002). Recently,
the administration of methylxanthines such as caffeine or theophylline has been
recommended as a BOLD contrast booster for studies confronted with a low SNR (Morton
et al 2002; Mulderink et al 2002). The methylxanthines are nonselective adenosine
receptor antagonists and block neurovascular receptors, predominantly A2, with a slightly
higher affinity than that of neural receptors, predominantly A1 (Dunwiddie et al 2001).
Blockade of vascular adenosine receptors produces vasoconstriction and decreases
resting cerebral perfusion (Dunwiddie et al 2001). This decrease in baseline cerebral
perfusion might enhance the BOLD signal (Dager et al 2000; Mulderink et al 2002), but
the relationship between cerebral perfusion and BOLD signal increase following caffeine
seems to be complex and not conclusive (Laurienti et al 2003).
In humans, Mulderink (2002) recently reported a considerable overall increase of 26-37%
in the BOLD-contrast in a visual (V1) and a motor area (M1) during the performance of a
visually cued motor task after administration of 200mg caffeine. In contrast, Laurienti et al.
(2002) found that the signal increase in visual cortex induced by visual stimulation
following caffeine intake is dependent upon the subjects’ dietary caffeine consumption; the
magnitude of the BOLD signal was significantly correlated with consumption. Additionally,
the BOLD signal change in visual cortex seemed to be restricted to high caffeine users
and might be explained by an upregulation of adenosine receptors.
The studies presented above used group-results. However, group results are not
necessarily representative for each individual subject. The use of a substance as signal
booster should systematically induce a signal increase in each subject. A contrast booster
in a clinical context would be helpful because low BOLD contrast is a major problem in the
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field of clinical fMRI diagnostics. In particular, the possibility of increased BOLD contrast in
the mesial temporal lobe (MTL) would be highly attractive. The MTL is one of the key
target regions in clinical fMRI diagnostics, for example in evaluating memory in
Alzheimer’s disease (Golby et al 2005) or in defining eloquent cortex in the presurgical
evaluation of refractory mesial temporal lobe epilepsy (Janszky et al 2005; Richardson et
al 2004). Unfortunately, the MTL is difficult to image because of its affinity for susceptibility
artefacts induced by its position and the differing magnetic properties of bone, tissue and
air in its vicinity (Powell et al 2004).
In addition to the difficulty in obtaining sufficient BOLD contrasts in single-cases, the
BOLD signal in patients can also be reduced by pharmacological effects. Antipsychotics,
for example, reduced the BOLD signal in the motor systems (Muller et al 2002).
Anxiolytics, anticholinergic drugs (lorazepam, scopolamine (Sperling et al 2002)) and
antiepileptic drugs (carbamazepine (Jokeit et al 2001b)) have been reported to reduce the
BOLD signal within memory-related MTL structures.
The use of a contrast booster would simplify fMRI measurements in clinical contexts and
caffeine would be very useful because of its easy and safe administration.
We therefore attempted to reproduce Mulderink et al’s group-results of an increased
percent BOLD signal change following caffeine in a single case, placebo controlled,
repeated fMRI study within three distinct domains, namely, within primary visual and
motor area and within memory-related MTL-structures.
5.1.2 Methods
5.1.2.1 Subjects
Six healthy volunteers (five males, aged 24-31) were enrolled in the study. They filled out
a questionnaire documenting their level of caffeine use. Four (subjects 1, 3, 4 and 6) were
high (2100-2800 mg/week) and two (subjects 2 and 5) low caffeine users (0 and 600
mg/week). Subjects were asked to refrain from ingesting any food or drink containing
caffeine (coffee, tea, soft drinks) 12h prior to their imaging time. No subject had been
treated with any medication one week prior to the fMRI measurements. Because
oestrogen level might have an effect on the size of BOLD-activation (Dietrich et al 2001),
cycle phases in the female subject were experimentally controlled over the four
measurements: fMRI experiments were conducted between the 12th and 17th day of the
menstrual cycle. Subjects gave written informed consent prior to the study after the
procedures were fully explained.
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5.1.2.2 Experimental design
Subjects performed eight fMRI runs on four different days with intervals of 1-4 weeks. The
runs included a visual, a motor and a memory paradigm. Each study day consisted of a
pre- and a post-treatment run: Day one: baseline-placebo, day two: baseline - caffeine,
day three: baseline - caffeine, day four: baseline-placebo. In the caffeine condition, either
100mg or 200mg of caffeine was administered (counterbalanced: three subjects had the
lower dose on the second day, and three subjects had the lower dose on the third day).
Post-treatment runs were performed 30 minutes after drug intake.
5.1.2.3 fMRI task design
The visual and the motor task was applied in one blocked paradigm. Seven blocks of the
visual paradigm and seven blocks of the motor paradigm were presented in an alternating
manner, each block lasted 30 seconds. During the visual block an on-off modulated black-
and-white checkerboard was presented at a frequency of 8Hz. In order to keep the
subject’s attention on the stimulus, red numbers appeared every 3 seconds in the centre
of the checkerboard. Subjects were instructed to read this number and to count upwards
in steps of two. Finger tapping was employed during the motor block. Subjects were
instructed to perform a rhythmic finger-to-thumb movement with their non-dominant hand.
Velocity of this finger tapping was 2.6Hz, paced on scanner noise. While tapping, the
subjects had to count upwards on steps of two.
The Roland’s Hometown Walking Task (Jokeit et al 2001c) was applied to activate
memory-related mesial temporal lobe structures. The paradigm consists of ten activation
blocks and ten baseline blocks, each with a duration of 30 seconds. During the activation
block, the subject has to retrieve spatio-temporal information from long-term memory. For
each subject, an individual hometown walk encompassing ten destinations was prepared.
Subjects were asked to mentally navigate through the ten different routes and to imagine
as many details as possible while navigating. After 30 seconds each route was interrupted
by the baseline task. The baseline condition consisted of covertly counting odd numbers
starting with 21. In preparation for fMRI, the subject had to fill out a familiarity
questionnaire of the landmarks. Only landmarks with high familiarity were included in the
individual hometown walks. Blocks with approximate routes (including similar type and
similar number of landmarks) of approximately 300 meters were included. To control for
memory performance during the fMRI-task, the subject was asked to write down the
starting and endpoint of the 10 walks after each fMRI-session. Each subject performed
each run adequately as indicated by a sufficient number of recalled landmarks.
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5.1.2.4 MR image acquisition
Structural and echo planar functional images were acquired on a 1.5 Tesla Magnetom
Sonata Scanner (Siemens, Erlangen, Germany). Subjects were positioned in the head coil
with ear pads and foam padding to reduce head motion.
A high resolution T1-weighted anatomical scan was acquired for each subject for
reference in single-subject analysis. The parameters for the anatomical sequence were as
follows: 176 axial slices with 1mm single-slice thickness, repetition time (TR) 1900ms,
echo time (TE) 3.93ms, 15° flip angle, field of view (FOV) 250mm, 256 x 256 matrix.
Functional data were acquired using EPI T2* weighted sequence. The following
parameters were applied in the visual, motor and memory paradigm: 20 slices, 5 mm slice
thickness (interslice gap: 1mm), repetition time (TR) 3000ms, echo time (TE) 50ms, 90°
flip angle, field of view (FOV) 250mm, matrix size 128 x 128 (voxel-size 3.9 x 3.9 x 5mm).
In the visual and motor paradigm, axial slices were oriented longitudinal to the AC-PC and
in the Roland’s Hometown Walking Task, coronal slices were oriented orthogonal to the
hippocampal formation covering the whole brain.
5.1.2.5 Data analysis
fMRI data analyses were performed with BrainVoyager 4.9.1 (BrainInnovation, Maastricht,
The Netherlands). The data were pre-processed with (1) three-dimensional motion
correction and (2) trend removal by temporal fast Fourier transform-based high-pass
filtering and transformed into Talairach co-ordinate space (Talairach et al 1988).
For multiple regression analyses, a general linear model (GLM) with the predictor for the
activation condition was computed. The time courses of the predictor were obtained by
using a linear model of the haemodynamic response. The overall model fit was assessed
by using an F statistic. Significant differences between the experimental conditions were
assessed by using contrast (t) maps.
A conjunction analysis was calculated over all subjects to define the region in which every
single subject revealed significantly activated voxels. In the centre of the observed
activation within the primary motor (M1), and the primary visual (V1) cortices, as well as in
the MTL, regions of interest (ROI) were defined by applying a cube with the size of 343
voxels (1mm3 isotropic voxels). Within these ROIs, group analysis were performed using a
general linear model (GLM) for the following contrasts: (1) baseline versus caffeine and
(2) baseline versus placebo. The contrasts were tested using t-statistics.
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For the analysis of the data on single-subject level, we computed in each subject a GLM
model including all runs. Then, individual ROIs were defined by applying a cube in the
centre of the activation with the size of 343 voxels (1mm3 isotropic voxels) within the
regions previously defined by the conjunction analysis in M1, V1 and MTL. Individual ROIs
were used in order to account for anatomical differences among subjects. Within these
regions, the data from the ROI were averaged for each individual measurement over the
time course to form the average percent BOLD signal change. These data were used for
the repeated measurement analysis of variance (RMANOVA). RMANOVA were
performed for (1) pre- versus post caffeine administration and (2) pre- versus post placebo
administration of averaged percent BOLD signal change in M1, V1 and MTL.
5.1.3 Results
Significant T2* contrast differences were found in each scan within primary motor area
(motor stimulation), primary visual area (visual stimulation) and within both MTL (Roland’s
Hometown Walking Task). In one subject, the first placebo measurement of the Roland
hometown walking task had to be excluded due to excessive head motion during the
scan. Figure 2 depicts overlap maps of conjunction analyses denoting significant
activations in each subject within the target areas.
Figure 2: Overlap maps of conjunction analysis denote significantly activated voxels in primary motor area
(motor stimulation), visual area (visual stimulation) and mesial temporal lobe (Roland’s
Hometown Walking Task) in 6 healthy volunteers (p < .001).
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Following placebo, the average percentage signal change in the BOLD response relative
to baseline revealed no difference between baseline and placebo condition in any
modality (ROI-GLM in M1: p = .12; in V1: p = .17 and in MTL: p = .75).
Within M1, group analyses revealed a significant signal increase following administration
of 200mg caffeine (ROI-GLM: t = 3.25, p < .001), whereas the intake of 100mg caffeine
did not enhance the average percent BOLD signal (ROI-GLM: t = -2.45, p = .179). The
significant contrast of ‘baseline versus 200mg caffeine condition’ is shown in figure 3.
Figure 3: Activation map of the general linear model with the contrasts ‘baseline vs. 200mg caffeine‘
(above) and ‚baseline vs. placebo‘ (beneath) in the motor task. Note significant increase
following 200mg caffeine intake and no significant effect following placebo within primary motor
area (M1).
Examination on a single-case level revealed signal increases in five out of six subjects, as
indicated in figure 4. Despite that, RMANOVA of the pre- versus post-treatment condition
failed to show a significant effect of 200mg caffeine (F (df = 1, n = 6) F = 4.4, p = .09,
eta2 = .47, Power = .39). Caffeine markedly increased the inter-individual variability
(variance coefficient v = 29%) compared to the baseline condition (v = 17%). The percent
BOLD signal change after intake of 200mg caffeine positively correlated with average
weekly caffeine consumption (r = .80, p < .05).
Within V1, average percent BOLD signal change was significantly decreased in group
analyses following administration of 100mg (ROI-GLM: t = -4.04, < .00001) and 200mg
(ROI-GLM: t = -7.43, p < .00001) of caffeine. Figure 5 depicts the significant decrease
within V1 of ‘baseline versus 200mg caffeine’.
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Figure 4: Differences between baseline and caffeine of the mean percent BOLD signal change within the
primary motor area (M1, black), the primary visual area (V1, grey) and the mesial temporal lobe
(MTL, white).
Figure 5: Activation map of the general linear model with the contrasts ‘baseline vs. 200mg caffeine‘
(above) and ‚baseline vs. placebo‘ (beneath) in the visual task. Note significant decrease
following 200mg caffeine intake no significant effect following placebo within primary visual area
(V1).
At an individual level we found increases of the BOLD-signal in two subjects and de-
creases with various magnitude in V1 in four subjects following administration of 200mg
caffeine (figure 4). Accordingly, RMANOVA of the pre- versus post-treatment condition
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failed to reveal a significant effect of any caffeine dose (100mg caffeine: F (df = 1, n = 6) =
.72, p = .44, eta2 = .13, Power = .11), 200mg caffeine: (F (df = 1, n = 6) = 0.7, p = .81,
eta2 = .02, Power = .06). Within V1, caffeine markedly decreased the inter-individual
variability (variance coefficient v = 19%) compared to the baseline condition (v = 37%).
Percent BOLD signal change after caffeine intake and average weekly caffeine
consumption were unrelated (p = .26).
As the visual and the motor paradigm were applied in one block-design, we looked for a
correlation of caffeine-induced signal alterations between these two regions. As indicated
in figure 6, we found no systematic correlation between M1 and V1 (spearman’s rho = .43,
p = .40).
Within MTL no significant alterations following caffeine intake were found, neither for
group analyses (ROI-GLM: 100mg caffeine: t = - .86, p = .39 and 200mg caffeine: t = -.05,
p = .65), nor in RMANOVA (100mg caffeine (F (df = 1, n = 6) = .004, p = .95, eta2 = .001,
Power = .05) and 200mg caffeine (F (df = 1, n = 6) = .20, p = .20, eta2 = .30, Power = .22).
These group data reflect the results at an individual level: four out of six subjects revealed
slightly decreased, one subject slightly increased BOLD signals and one subject did not
show any signal alterations following 200mg caffeine (figure 4). Within MTL, caffeine did
not have any influence on the inter-individual variability (variance coefficient caffeine: v =
56%, and baseline v = 52%). Again, percent BOLD signal change after caffeine intake and
average weekly caffeine consumption were unrelated (p = .82).
Figure 6: Caffeine-induced signal alterations in primary visual area (V1) compared to primary motor area
(M1).
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5.1.4 Discussion
Recently, Mulderink and co-workers (2002) suggested the use of caffeine as a BOLD
contrast booster for studies confronted with low SNR. The authors reported a
considerable overall increase of 26-37% after administration of 200mg caffeine in the
BOLD-contrast in a visual (V1) and a motor area (M1) during the performance of a visually
cued motor task. We attempted to reproduce the reported group- results by Mulderink and
co-workers (2002) in a single case, placebo controlled, repeated fMRI study within primary
visual and motor area and adapted these techniques to memory-related MTL-structures.
Our study confirmed the group analyses that 200mg of caffeine enhances the BOLD-
contrast in M1 while performing a motor task (ROI-GLM: p < .001), although the more
conservative RMANOVA showed only a trend (p = .09). The increase of BOLD signals
following caffeine was clearly correlated with dietary caffeine consumption. This
observation is in accordance with Laurienti (2002), who reported significantly higher BOLD
signal changes among high caffeine users compared to low caffeine users. However,
even if caffeine boosts the percent BOLD signal in group analyses, the results at a single-
case level are less convincing. The administration of caffeine led to a marked increase of
inter-individual variability. It has therefore to be concluded that the administration of
caffeine may boost the BOLD signal in M1 in some subjects, but it can also act as a
confounding variable as well.
Within V1 we failed to reproduce the reported signal increase following administration of
200mg caffeine. In contrast, group analyses showed that caffeine decreased the BOLD-
signal in V1 (p < .00001). Also, at an individual level we found frequent decreases in the
BOLD-contrast in V1. The lack of convincing effects was statistically confirmed by
applying an RMANOVA model (p = .81). This result is in contrast to previous reports of
Mulderink et al. (2002) who found a signal increase in V1. However, as can be seen in
figure 2a in their report, the standard deviation of the percent BOLD signal change in V1 is
about three times higher than the mean, indicating that there are considerable inter-
individual differences and deviations from the normal distribution. Therefore, their finding
seems to be less convincing than the reports of increased signals following caffeine intake
in M1. Our results are in agreement with the results of Laurienti et al. (2002) who
demonstrated signal decreases as well as signal increases during a visual paradigm as a
function of the individual caffeine consumption. Moreover, they controlled for cerebral
perfusion and found that despite consistently reduced perfusion states in all study
participants, no more than 47% of the participants demonstrated an increase in BOLD
signal intensity in response to caffeine (Laurienti et al 2003).
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Within the MTL we failed to find any effects following caffeine administration and
moreover, the signal-change was not related to dietary caffeine consumption. Only one
subject revealed a slight increase in the BOLD response following caffeine intake.
Regarding the influence of dietary caffeine consumption on the BOLD-contrast, we only
found a positive correlation in M1. These results might be in line with the recent
observation that the resting cerebral perfusion may be differentially affected in different
regions by caffeine (Field et al 2003). The motor cortex belongs to the vascular territory of
the anterior and middle cerebral arteries (called the anterior circulation), whereas the
primary visual cortex and partially the mesial temporal lobe are supplied by the posterior
cerebral arteries (called posterior circulation). The authors found a significant interaction
effect between dietary caffeine use and cerebral blood flow (CBF) response to caffeine
only in the anterior circulation and not in the posterior circulation. This apparent difference
between the studied regions might be explained by regional variations in the number of
perivascular adrenergic nerves, adenosine receptors or nucleoside transport proteins
(Field et al 2003).
With regard to dosage, the administration of 100mg caffeine did not show any consistent
effects on the reported brain areas. The 200mg dose was chosen as Mulderink and co-
workers (2002) and Laurienti (2002) administered a caffeine in this range, namely 200mg
(Mulderink et al 2002) and 250mg (Laurienti et al 2002).
In summary, our study confirmed with group analyses that 200mg caffeine enhances the
BOLD-contrast in M1 while performing a motor task (ROI-GLM: p < .001). However, closer
examination was less convincing as the use of the more conservative RMANOVA
revealed only a trend (p < .09), and a marked increase in inter-individual variability was
found. Within V1 and MTL, caffeine seems to provide no consistent boosting effects.
On an intra-individual level we found clearly domain-specific effects. Following the
administration of caffeine subject one, for example, showed a marked signal increase in
M1, whereas caffeine had only a slight influence on V1 and no effect within the MTL.
Subject 3 showed (although the signal increased following caffeine intake in M1 and
slightly in MTL) a marked decrease in V1. In subject 6 finally, caffeine had a boosting
effect in M1 and in V1, whereas the signal decreased in MTL following caffeine. All three
subjects were high caffeine users and should, according to the results of Laurienti (2002),
show consistent increases in the BOLD signal at least in M1 and in V1.
Although previous studies found some boosting effects on the BOLD response following
caffeine administration, we conclude that caffeine seems to be far less effective as a
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BOLD contrast booster than expected. Our results discourage the use of caffeine in a
clinical context as it may enhance inter-individual variability and may even reduce the
signal in certain subjects. Moreover, in our study caffeine related BOLD-contrast changes
were clearly domain specific within individual subjects.
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5.2 Second study: Reproducibility of serial fMRI scans
within MTL
5.2.1 Introduction
The distinct advantages of fMRI include its non-invasiveness, relatively high spatial and
for many purposes sufficient temporal resolution, and the ease of imaging underlying
anatomy. Serial investigations can be safely performed with fMRI (Turner et al 1997) and
therefore it seems to be the method of choice for studying longterm changes in brain
function. Possible applications of serial investigations in a clinical setting are the
evaluation of functional changes during progressive neurological diseases, especially
neurodegenerative disorders such as dementia, the investigation of plastic changes that
occur in the brain during recovery, or the examination of the influence of longterm
pharmacological treatments such as antiepileptic drugs in epilepsy patients.
The validation of serial fMRI-investigations can be viewed to the retest-reproducibility of
the activation pattern (qualitative approach) or to the retest-reproducibility of the activation
magnitude and the spatial extent (quantitative approach). The quantitative approach
describes any changes within a given structure that occur in the brain during recovery,
pathological processes or treatments.
Unfortunately, many factors can affect the BOLD response and may lead to high variability
across fMRI sessions. In addition to technical factors such as instability of the scanner or
drifts of the mean magnetic field during the scanning session, psychological phenomena
(e.g. attention) or physiological factors (e.g. oxygen saturation) can influence the shape,
duration and the intensity of the BOLD response. The particular proportion of each of
these factors to the variability is still not completely understood. Among the psychological
factors, however, it has been shown that the reproducibility of quantitative fMRI results
varied with the attentional load showing the highest concordance with high attentional
effort (Specht et al 2003). Other observations suggested that global physiological rather
than task-related factors contribute to the variability of quantitative fMRI-results: in serial
examinations of a visual and a motor paradigm, a high correlation between the variability
of the two simultaneously applied paradigms was found (Waldvogel et al 2000).
Physiological factors including oxygen saturation (Weckesser et al 1999), diet factors such
as lipid ingestion (Noseworthy et al 2003), ingestion of bioactive compounds (Leslie et al
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2000) or more complex biological factors such as diurnal factors and phase of menstrual
cycle (Dietrich et al 2001) may also cause global activation changes.
Therefore, the evaluation of patients in serial examinations requires validation of the target
paradigm with respect to the long-term reproducibility of the results. The longterm-
reproducibility of fMRI results with more than three scans has rarely been investigated.
Recently, Wei (2004) reported small longitudinal variability of activation in a working-
memory task over 9 scans. However, the study used a multi-subject analysis which is not
necessarily representative for individual subjects. Investigations in a clinical context
require results at a single-subject level which seems to be far more variable. McGonigle
and co-workers (2000) repeated a cognitive task (generating random numbers) 33 times
on a single subject and found widely varied activated voxels over repeated sessions. High
intra-individual intersession variability was also reported in a serial fMRI study with 6
weekly scans in which six subjects performed a visual and a motor task weekly
(Waldvogel et al 2000).
To our knowledge, there is only one study reporting quantitative retest-reproducibility of
fMRI investigations within the MTL. Using a visual encoding task Machielsen and co-
workers (2000) reported substantial variations in the quantitative analysis of fMRI results
in three repeated scans on two days. The longterm-reproducibility of repeated fMRI scans
is of interest because these structures are among the key target regions in clinical fMRI
diagnostics such as the evaluation of memory-related eloquent cortex in Alzheimer’s
disease (Golby et al 2005) or mesial temporal lobe epilepsy (Golby et al 2005; Janszky et
al 2005; Richardson et al 2004).
Therefore, the present study deals with the possibility of investigating longitudinal effects
within this region. We used the Roland’s Hometown Walking Task (Jokeit et al 2001c) to
activate memory-related MTL structures. This paradigm has been shown in many studies
to reliably activate the MTL bilaterally on a single-subject level such as in MTLE patients,
patients with low formal IQ, children, older subject and subjects from other cultures (Avila
et al 2004; Janszky et al 2005; Janszky et al 2004; Jokeit et al 2001b; Jokeit et al 2001c).
The advantage of this paradigm is its practicability, reliability and its close relation to
every-day memory demands.
We investigated whether this paradigm is robust enough to provide reproducible and
detectable activations over a relatively long period. Although we already know that there is
a large intra-individual variability in activation across sessions, we aimed to describe the
variability over several scans. We explored (1) how stable the data are on a single-subject
level and (2) in group analyses. We (3) explored whether there are specific factors such
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as behavioural variables or time factors which explain the variability. Answers to these
questions are indispensable for distinguishing between the variations inherent in the
examination method and the changes in subjects’ brain due to recovery, pathological
processes or treatment effects.
5.2.2 Materials and methods
5.2.2.1 Subjects
Six healthy volunteers (five males, aged 24-31) were enrolled in the study. The subjects
were trained to perform the fMRI tasks which they also rehearsed immediately before
undergoing each fMRI scan to minimise any residual learning effects. Because oestrogen
level might have an effect on the size of the BOLD-activation (Dietrich et al. 2001), cycle
phases in the female subject were experimentally controlled over the four measurements:
fMRI experiments were conducted between the 12th and 17th day of the menstrual cycle.
All subjects has not been treated with any medication one week prior to the fMRI
measurements. Subjects were asked to refrain from ingesting any food or drink containing
caffeine (coffee, tea, soft drinks) 12h prior to their imaging time and to refrain from
ingesting any food or drink containing ethanol 24h prior to their imaging time. Subjects
were instructed to maintain their usual diet. Three subjects were smokers (subject 2, 3, 4).
Their smoking habits were assessed and the subjects were asked to maintain time and
amount of nicotine intake within the 12h prior to their imaging time. Caffeine, ethanol
consumption and smoking habits were reassessed on every scan day. Subjects gave
written informed consent prior to the study after the procedure have been fully explained.
5.2.2.2 Experimental design
Subjects were examined six times with a modified version of the Roland’s Hometown
Walking Task (Jokeit et al 2001c). Measurements were performed on four different days
with intervals of 1-4 weeks. Each subject underwent the fMRI measurements at the same
time of day to minimise any natural diurnal variations. On the first and the fourth day, two
scans were performed. Subjects were repositioned from the scanner between the two
scans. On the second and third day, only a single scan was performed (scan number 2
and 3). To summarise, two within-day measurements and four between-day measure-
ments were performed.
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5.2.2.3 fMRI task design
The Roland’s Hometown Walking Task (Jokeit et al 2001c) was applied to activate
memory-related MTL structures. The paradigm consisted of ten activation blocks and ten
baseline blocks, each with a duration of 30 seconds. During the activation block, the
subject has to retrieve spatio-temporal information from long-term memory. For each
subject, an individual hometown walk encompassing ten destinations was prepared.
Subjects were asked to mentally navigate through the ten different routes and to imagine
as many details as possible while navigating. After 30 seconds each route was interrupted
by the baseline task. The baseline condition consisted of covertly counting odd numbers
starting with 21. In preparation for fMRI, the subject had to fill out a familiarity
questionnaire of the landmarks. Only landmarks with high familiarity were included in the
individual hometown walks. Blocks with approximate routes (including similar type and
similar number of landmarks) of approximately 300 meters were included. To control for
memory performance during the fMRI-task, the subject was asked to write down the
starting and endpoint of the 10 walks after each fMRI-session. Each subject performed
each run adequately as indicated by a sufficient number of recalled landmarks.
5.2.2.4 MR image acquisition
Structural and echo planar functional images were acquired on a 1.5 Tesla Magnetom
Sonata Scanner (Siemens, Erlangen, Germany). Subjects were positioned in the head coil
with ear pads and foam padding to reduce head motion.
A high resolution T1-weighted anatomical scan was acquired for each subject for re-
ference in single-subject analysis. The parameters for the anatomical sequence were as
follows: 176 axial slices with 1mm single-slice thickness, repetition time (TR) 1900ms,
echo time (TE) 3.93ms, 15° flip angle, field of view (FOV) 250mm, 256 x 256 matrix.
Functional data were acquired using an Echo Planar Imaging T2* weighted sequence with
the following parameters: 20 slices, 5mm slice thickness (interslice gap: 1mm), repetition
time (TR) 3000ms, echo time (TE) 50ms, 90° flip angle, field of view (FOV) 250mm, matrix
size 128 x 128 (voxel-size 3.9 x 3.9 x 5mm). Coronal slices were oriented orthogonal to
the hippocampal formation covering the whole brain.
5.2.2.5 Data analysis
Functional MRI data analyses were performed with BrainVoyager 4.9.1 (BrainInnovation,
Maastricht, The Netherlands). The data were pre-processed with (1) three-dimensional
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motion correction and (2) trend removal by temporal fast Fourier transform-based high-
pass filtering and transformed into Talairach co-ordinate space (Talairach et al 1988).
For multiple regression analysis, a general linear model (GLM) with the predictor for the
activation condition was computed. The time courses of the predictor were obtained by
using a linear model of the haemodynamic response. The overall model fit was assessed
using an F statistic. Significant differences between the experimental conditions were
assessed using contrast (t) maps.
Number of significantly activated voxels were specified on the functional map in each
measurement separately with a predefined statistical threshold of p < .00001. The
functional cluster was caudally constrained by the crus of the fornix. For each VOI the
number of activated voxels was counted in the left and right hemisphere.
To collect the percent BOLD signal change data within the parahippocampal gyrus, VOIs
with similar cluster sizes were defined using the following method: A conjunction analysis
was computed to define the region in which every run of each subject revealed
significantly activated voxels. Then, individual VOIs were defined by applying a cube with
the size of 343 voxels (1mm3 isotropic voxels) in the centre of the activation in order to
cover the most activated voxels (Bosch 2000). Individual VOIs were used in order to
account for anatomical differences among subjects. Within these defined VOIs, time
course epochs corresponding to the conditions were averaged together and the percent
BOLD signal change was collected for each subject.
We then evaluated the longterm-stability on a single-case level, first by terms of the
coefficient of variance (v). It is calculated by dividing the standard deviation by the mean
and then by multiplying the result by 100:
v = (SD / mean) * 100
The advantage of this measure is that it represents a relative standard deviation, since it
takes into account the mean. The larger the value, the greater is the variability in the data.
In order to describe the longterm-stability intra-individually, we computed the relative
deviation from the first scan. A scan was classified to be stable, when the deviation was in
between one standard deviation.
To estimate the test-retest reliability by multi-subject analysis, we computed the intraclass
correlation coefficient (ICC). This measure was used to quantify the retest-reliability of the
activation extent (significantly activated voxels) and the activation intensity (percent BOLD
signal change). The ICC represents the difference between within- and between- subject
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variability. It approaches 1 when the within-subject variability is low. Most of the observed
variance can then be explained by the between-subject variability (Moser et al 1996).
To explore whether the variability depends on time or repetition effects, we computed
repeated measurements analysis of variance (RMANOVA).
5.2.3 Results
The modified version of the Roland’s Hometown Walking Task led to significant T2*
contrast differences within both MTL in all of the 36 measurements (p < .00001; except 4th
measurement in subj. 6: right MTL p < .0006). In one subject, the second scan of the first
day had to be excluded due to excessive head motion during the scan.
To quantify the activation, two different dependent variables were exploited in the data
analysis. First, we present the spread of activation in terms of significantly activated
voxels and second the magnitude of activation, indicated as the percent BOLD signal
change.
How stable are the numbers of significantly activated voxels on single-subject level?
Basically the variance coefficients were high in all subjects (table 1). There were subjects
with relatively low variance coefficients (e.g. in subject 2) and those with extremely high
variance coefficients (e.g. in subject 3).
Table 1:   Variance coefficients (v) of significantly activated voxels in each subject
Subject v (right MTL) v (left MTL)
1 83% 122%
2 69% 66%
3 115% 142%
4 82% 92%
5 82% 92%
6 75% 88%
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There was a high variability of the activation level referred to the number of significantly
activated voxels (p < .00001) between subjects (figure 7). Subject one for example
activated a relatively low number of significantly activated voxels (mean = 759, ± 578 SD),
whereas subject two revealed high numbers of activated voxels (mean = 3305; ± 2012
SD). Within subjects, the numbers of significantly activated voxels varied markedly as
indicated in figure 7.
right MTL
0
2000
4000
6000
8000
1 2 3 4 5 6
subjects
si
gn
.
 
a
ct
iv
a
te
d 
vo
xe
lss
1st scan 2nd scan 3rd scan 4th scan
5th scan 6th scan
left MTL
0
2000
4000
6000
8000
1 2 3 4 5 6
subjects
si
gn
.
 
a
ct
iv
a
te
d 
vo
xe
lss
1st scan 2nd scan 3rd scan 4th scan
5th scan 6th scan
Figure 7: Absolute numbers of significantly activated voxels (p < .00001) in six serial scans in each subject
As far as the level of activation varied between subjects, we investigated their impact on
the variances. There was no significant correlation between the mean of significantly
activated voxels and variance coefficients (right MTL: spearman’s rho = -.72, p = .10, left
MTL: spearman’s rho = -.23, p = . 66).
In order to describe the longterm-stability intra-individually, we computed the relative
deviation of number of significantly activated voxels from the first scan (figure 8). The
mean of the relative deviation was within the right MTL 44.7% (± 27.5% SD) and within
the left MTL 24.6% (± 34.2% SD). The greatest within-subject variability range was 0.46%
to 129% (3, left MTL).
A different approach to describe the stability of scans on a single-subject level is to
threshold them as stable, when the deviation from the first scan is less than one standard
deviation. Regarding both MTL simultaneously, we found in one single subject (subject 4)
three stable scans out of five scan-repetitions (figure 9). Within the scan series and
unrelated to the first scan, there were more scans with deviations within one standard
deviation (figure 9). All subjects revealed at least two stable scan-repetitions.
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Figure 8: Relative frequency of significantly activated voxels in six serial scans in each subject
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Figure 9: Frequency of ‘stable’ scans (the deviation from the reference scan was less than one standard
deviation) of significantly activated voxels
Are the significantly activated voxels reproducible on group level over scans?
Reproducibility was tested on a group level by performing intraclass correlation
coefficients (ICC). The ICC for the significantly activated voxels within the right MTL was
.74 and within the left MTL .78. This indicates that the significantly activated voxels were
reproducible over scans on group level.
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How much vary the numbers of significantly activated voxels on group level?
The mean of the number of significantly activated voxels over all subjects and scans
within the right MTL was 1939 (± 1198 SD) and within the left MTL 2628 (± 1655 SD). The
variance coefficient within the right MTL was 62% and within the left MTL 63%.
The averaged values over all subjects of the six scans are indicated in figure 10. We
computed the relative deviation of averaged number of significantly activated voxels. The
reference scan was the first scan. The mean relative deviation between scans of
averaged number of significantly activated voxels was 22.4 (± 19.8 SD) in the right MTL
and 23.3 (± 22.5 SD) in the left MTL.
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Figure 10: Averages of the significantly activated voxels in six serial scans
Are there specific factors explaining the variability of number of significantly activated
voxels?
We investigated whether the following factors might explain the variability of the number of
significantly activated voxels:
Days between scans: There was no significant effect whether the scans were performed
within one day or between several days: The RMANOVA failed to reveal a significant
difference between the scans obtained within one day in contrast to the scans obtained
between days of the right- and the left-sided MTL voxel counts (right MTL: F(1,5) = 1.33,
p = .31, eta2 = .25, Power = .15; left MTL: F(1, 5) = .32, p = .15, eta2 = .44, Power = .28).
Repetition: There was no significant linear decrease over the six scans in the right MTL
(RMANOVA: F(1,5) = .88, p = .40, d = .18, Power = .11) and in the left MTL (F(1,5) = 2.34,
p = .20, d = .37, Power = .22).
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Behaviour: Variability was not related to the behavioural performance, as far as no
significant correlations were found between the numbers of significantly activated voxels
and the numbers of remembered startings and endpoints (right MTL r = .03, p = .88; left
MTL r = .06, p = .76).
How stable are the percent BOLD signal changes on single-subject level?
The variance coefficients were in all subjects on a high level (table 2) with extremely high
values in subject 5.
Table 2:   Variance coefficients (v) of the percent BOLD signal change in each subject
Subject v (right MTL) v (left MTL)
1 114% 83%
2 97% 88%
3 68% 98%
4 72% 83%
5 109% 128%
6 103% 57%
Figure 11 shows the variability of the percent BOLD signal change on a single-subject
level. There was a high variability of the activation level referred to the percent BOLD
signal change (p < .00001) between subjects (figure 11). The highest percent BOLD
signal change was 1.59 (± .69 SD, subject 3), the lowest was .78 (± .30 SD, subject 5).
Activation level had no impact on variability as far as there were no significant correlations
between the mean of the percent BOLD signal change and the variance coefficients (right
MTL: spearman’s rho = -.26, p = .62, left MTL: spearman’s rho = .54, p = . 27).
In order to describe the longterm-stability intra-individually, we computed the relative
deviation of the percent BOLD signal change from the first scan (figure 12). The mean of
the relative deviation was within the right MTL 27.3 (± 17.8 SD) and within the left MTL
27.6 (± 16.8 SD).
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Figure 11: Percent BOLD signal change in six serial scans in each subject
The greatest within-subject variability range was 7.8% to 98.4% (5, right MTL). We
considered a repeated scan to be stable when the deviation from the first scan was within
one standard deviation. Using this definition, we found no more than three subjects who
had two or three ‘stable’ scan-repetitions (figure 13). Unrelated to the first scan, there
were more ‘stable’ scans. Four out of six subjects (1 to 4) revealed three or four stable
scans repetitions within either the left or the right MTL.
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Figure 12: Relative percent BOLD signal change in six serial scans in each subject
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Figure 13: Frequency of ‘stable’ scans (the deviation from the reference scan was less than one standard
deviation) of the percent BOLD signal change
Are the percent BOLD signal changes reproducible on group level over scans?
Reproducibility was tested on a group level by performing intraclass correlation
coefficients (ICC). The ICC of the percent BOLD signal change was for the right MTL .73
and for the left MTL .91. This indicates that the significantly activated voxels were on
group level reproducible over scans.
How much vary the percent BOLD signal changes on group level?
The mean of the percent BOLD signal change over all subjects and scans within the right
MTL was .99 (± .38 SD) and within the left MTL 1.06 (± .57 SD). The variance coefficient
within the right MTL was 38% and within the left MTL 54%. The averaged values over all
subjects of the six scans are indicated in figure 14.
Are there specific factors explaining the variability of the percent BOLD signal changes?
We investigated, whether the following factors might explain the variability of the percent
BOLD signal change.
Days between scans: The RMANOVA failed to reveal a significant difference between the
scans obtained within one day in contrast to the scans obtained between days of the
percent BOLD signal change within the right MTL and the left MTL (right MTL: F(1,5) =
1.33, p = .31, eta2 = .25, p = .15).
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Repetition: There was no significant linear decrease over the six measurements in the
right MTL (F(1,5) = 1.02, p = .37, d = .20, Power = .12) and in the left MTL (RMANOVA:
F(1,5)= 3.6, p = .12, d = .48, Power = .31).
Behaviour: The variability was not related to behavioural performance, as there was no
significant correlation between the percent BOLD signal change and the numbers of
remembered startings and endpoints (right MTL r = -.29, p = .16; left MTL r = .18, p = .39).
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Figure 14: Averages of the percent BOLD signal change in six serial scans
Which measure is more stable: the number of significantly activated voxels or the percent
BOLD signal change?
The relative deviations from the first scan were significantly higher in the number of
significantly activated voxels compared to the percent BOLD signal change (paired t-test:
MTL right: t (23) = 2.7, p = .01; paired t-test: MTL left: t (23) = 2.5, p = .02). The variance
coefficients were comparable in both measure (paired t-test: MTL right: t(5) = -.73, p = .49;
paired t-test: MTL left: t (5) = .79, p = .46). There were no differences between the ICC
values of significantly activated voxels compared to the percent BOLD signal change
(paired t-test: MTL right: t (14) = -.77, p = .45; paired t-test: MTL left: t (14) = -1.9, p = .07).
5.2.4 Discussion
The aim of the present study was to describe the longterm reproducibility of fMRI-BOLD
signals within the MTL in order to be able in future investigations to distinguish between
variations inherent in the examination method and changes in subjects’ brain activation
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due to functional recovery, pathological processes or treatment effects. As investigations
in a clinical context require results on a single-subject level, we first investigated the intra-
individual stability of serial fMRI scans.
The Roland’s Hometown Walking Task led to significant activations within both MTLs in
each scan in each subject. The intra-individual variability in quantitative measures such as
the number of significantly activated voxels and the percent BOLD signal change was high
across the scans as indicated in several observations. First, in all subjects we observed
high variance coefficients. Regarding the number of significantly activated voxels, we
found values of up to 142% and regarding the percent BOLD signal of up to 114%.
Differences in amount of activation among subjects did not contribute to the level of
variability. Subjects with lower amounts of activation (less significantly activated voxels or
lower percent BOLD signal change over all six scans) did not show decreased or
increased variance coefficients compared to subjects with a higher activation level.
Second, the relative deviations between scans were up to 129% for the number of
significantly activated voxels and up to 98% for the percent BOLD signal change. These
deviations were in the range of previously observed changes in primary visual and motor
areas. The variability of repeated runs ranged intra-individually between zero and several
thousand significantly activated voxels (McGonigle et al 2000; Miki et al 2000). Moser and
co-workers (Moser et al 1996) reported standard deviations of significantly activated
voxels typically in the range of 20-50% but with values of up to 100%. Regarding the
percent BOLD signal change Waldvogel and co-workers (2000) observed an extremely
high intersession variability in a serial fMRI study in which six subjects performed a visual
and a motor task. In the motor task, for example, the percentage of deviation of the
activation amplitude from the first scan increased up to 192%.
Third, we found no single subject with consistently stable scans over all repeated scans. A
scan was considered to be stable when the relative deviations between scans were within
one standard deviation. A higher number of stable scans were observed, when any
another scan and not the first scan was the reference. Nevertheless, the most ‘stable’
subject revealed no more than four stable out of five scan repetitions in either measure.
Therefore, one of the main findings of our study is that the variability within our data on a
single-subject level was high on both dependent variables, i.e. the number of significantly
activated voxels and the percent BOLD signal change. Our study corroborates previous
findings of high intra-individual variability of fMRI results observed in primary sensory and
motor tasks. The new finding is that we found a high intra-individual variability of fMRI
results within the MTL. It has to be concluded that the quantitative interpretation is not a
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reliable method to study longterm effects of brain functions at a single-subject level. A
quantitative analysis of the data is possibly a more reliable method for the single-case
investigation.
The second part of the study investigated quantitative reproducibility on group level. First,
we investigated the reproducibility by determining the intraclass correlation coefficient
(ICC). The ICC encompasses the difference between within and between-subject
variability and approaches one when within-subject variability is low. The ICC values for
the number of significantly activated voxels were .74 (right MTL) and .78 (left MTL) and for
the percent BOLD signal change .73 (right MTL) and .91 (left MTL). These values indicate
a lower contribution of within-subject variability to the overall variability which in turn
means, a greater contribution of between-subject variability.
Second, we investigated the amount of variance of the significantly activated voxels and
the percent BOLD signal change by calculating variance coefficients. The values were in
the midrange, with coefficients between 62% and 63% (right and left MTL) for the number
of significantly activated voxels and 38% and 54% (right and left MTL) for the percent
BOLD signal change.
A considerable amount of variance may, of course, be explained by global technical (i.e.
instability of the scanner or drifts of the mean magnetic field during the scanning session)
or physiological factors. We experimentally controlled the physiological factors caffeine,
ethanol, nicotine and drug intake over the six scans. Additionally, the scans were
performed on the same daytime to rule out any diurnal effects.
We statistically controlled for several factors that might also explain the variability such as
time (within-day scans in contrast to between-day scans and repetition effects) as well as
behavioural effects. None of these factors explained a significant proportion of the
observed variability. Interestingly, neither the comparison of within-day scans to between-
day scans, nor repetition effects contributed significantly to the explanation of the
variability. Regarding the repetition effects, adaptation or habituation effects might have
been expected with increasing time and repetition. Changes related to cognitive practice
have also been examined by using fMRI. A common finding in fMRI studies is a reduced
haemodynamic response for repeated relative to unrepeated stimuli (Henson et al 2003).
However, in contrast to our experiment, previous studies used single session
experimental designs. Moreover, the Roland’s Hometown Walking Task uses the retrieval
from longterm memory traces consolidated several years before the test situation and is
therefore probably highly automated.
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Machielsen and co-workers (2000) suggested behavioural effects as one possible factor
of activation variance. They reported a correlation between behavioural measures
(subsequent recognition of pictures which were encoded during scanning) and mean
activation volume per subject. In contrast, we observed no behavioural effect explaining
the variability by investigating the correlation between the behavioural performance
(recalled startings and endpoints) and the numbers of significantly activated voxels or the
percent BOLD signal change.
Finally, we found no difference comparing the variance of the number of significantly
activated voxels and the percent BOLD signal change. There are controversial
suggestions whether to use the number of significantly activated voxels or the amplitude
in terms of percent BOLD signal change to define reproducibility. Previous studies
observed that the magnitude of activation indicated in percent BOLD signal change is
more stable than the number of significantly activated voxels (Cohen et al 1999;
Waldvogel et al 2000). On the other hand, Machielsen and co-workers (Machielsen et al
2000) suggested that counting the activated voxels is a reliable method. Of course, the
reliability of the selected measure depends on the postprocessing method.
A confounding variable in the number of significantly activated voxel is the statistical
threshold chosen. The definition of the threshold is artificial and it might be more
appropriate to use individually adjusted thresholds because of the highly variable
activation levels between subjects. On the other hand, previous studies showed that
different significance levels did not show large deviations in reproducibility when they are
near Bonferroni corrected significance thresholds (Rombouts et al 1998). Additionally, the
reproducibility of significantly activated voxels can be obtained by using preselected
areas. In our study of the MTL, we used a very conservative statistical threshold to count
the significantly activated voxels and used predefined regions of interest. A confounding
variable with regard to the percent BOLD signal change is probably the selected region of
interest, in which the magnitude of activation is defined. Of course, we used a very
conservative approach. The region of interest in each subject was predefined by a
conjunction analysis and we then applied a small 3D volume in the centre of activation in
each scan in order to cover the most activated voxels.
A further main finding of our data is that the quantitative reproducibility on a group level is
promising for the investigation of serial fMRI scans. Nevertheless it has to be concluded
that there is a considerable amount of variability in the data. Probably one cannot expect a
higher stability of cognitive neurophysiological measures in general. Reliability estimates
of the P3 component of event-related potentials, for example, were reported to be in the
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same range observed in fMRI studies, both over various time intervals (Segalowitz et al
1993; Walhovd et al 2002) and serial examinations (Kinoshita et al 1996).
Because of the remaining substantial variation, investigations of longterm effects on brain
functions should rely on group-designs with serial investigations. Additionally, meaningful
data can only be expected when strong treatment or recovery effects are anticipated, i.e.
with signal changes of certainly more than 30-40%. These estimates are based on the
amount of the relative deviation between scans in our study and account for the high
standard deviation. Two recent pharmacological fMRI studies probably used potent
substances and therefore observed substantial variations in the BOLD response (Jokeit et
al 2001b; Sperling et al 2002). Both the anticholinergic drugs lorazepam and scopolamine
(Sperling et al 2002) and the antiepileptic drug carbamazepine (Jokeit et al 2001b)
considerably decreased the BOLD signal within the MTL. Compared to a placebo-
condition, lorazepam and scopolamine decreased the significantly activated voxels within
the hippocampus by approximately 40-60% and the percent BOLD signal change by
approximately 50-60%. When only high doses of carbamazepine (serum levels of more
than 7 mg/l) are included, the proportion of significantly activated voxels within the MTL
was decreased by approximately 50% as compared to a control group. As the latter study
used a cross-sectional study design, it is necessary to replicate this result in a longitudinal
group-study.
To summarise, we found substantial intra-individual variability in both the number of
significantly activated voxels and the percent BOLD signal change within the MTL in six
serial fMRI scans. We concluded that the quantitative interpretation is not a reliable
method for studying longterm effects of brain functions at a single-subject level. However,
at a group level, we found reasonable reproducibility, indicated by sufficient ICC values.
These results should not discourage the application of serial fMRI scans to investigate the
plasticity of changes, to evaluate the functional evolution of chronic neurological diseases,
or to study the influence of longterm pharmacological treatments. However, its application
is limited to its use in longitudinal group studies and to the evaluation of substantial
influences on the brain functions such as pharmacological agents with a high impact.
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5.3 Third study: Amygdala fMRI in mesial temporal lobe
epilepsy: feasibility, reproducibility, and clinical
experiences
5.3.1 Introduction
Mesial temporal lobe epilepsy (MTLE) is the most frequent form of focal epilepsy in adults
(Engel et al 1997), and epileptic seizures typically arise from the inner parts of the MTL
(Mathern et al 2002). Mesial temporal lobe epilepsy is typically characterised by sclerosis
of the hippocampal formation (Blumcke et al 2002). Hippocampal sclerosis is most often
found in conjunction with amygdala damage, but, as indicated by analysis of histological
sections and MRI, may also be restricted solely to the amygdala (Blumcke et al 2002;
Miller et al 1994; Pitkanen et al 1998). In the majority of patients, MTLE is refractory to
medical treatment (Kim 2001). In these patients, temporal lobe surgery is the treatment of
choice. Standard surgical techniques are selective amygdala-hippocampectomy and
anterior temporal lobectomy with resection of the hippocampal formation, the amygdala,
and, depending on the surgical approach, lateral temporal neocortex (Kim et al 2001).
The high vulnerability and epileptogenic disposition of the hippocampus and adjacent
anatomically related MTL structures coincides with its importance for learning and
memory (Eichenbaum 1999; McGaugh 2000). Unilateral MTL damage typically leads to
material specific memory impairment (Hermann et al 1992; Pillon et al 1999). Thus,
memory deficits are a major complication of TLE surgery (Kapur et al 2003; Pilcher et al
1993).
Beyond the function of MTL structures in memory, the anterior temporal lobe (TL), namely
the amygdala, is one of the key structures involved in emotional processing. Lesion and
imaging studies emphasise its importance in conditioning of autonomic responses
(Bechara et al 1995), emotional memory (Brierley 2004; Cahill et al 1995), and in social
perceptual skills such as recognising facial expression (Adolphs 2003), and emotional
behaviour (Tranel et al 1990). Impairments following unilateral TL surgery may thus cause
problems in emotional processing, including social behaviour and specific functions of
social and emotional cognition (Adolphs et al 2001; Anderson et al 2000; Brierley et al
2004; Hermann 2002). However, the question of whether certain impairments following TL
surgery are related to resected parenchyma of the amygdala is a matter of controversy.
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Due to the functional importance of MTL structures, the benefit of surgery must be
assessed relative to possible deficits. Presurgical diagnostics aims at identifying eloquent
cortex to avoid disabling deficits. To date, presurgical diagnostics in refractory MTLE
patients has mainly addressed memory-related structures. In contrast, postsurgical
changes related to different degrees of amygdalar dysfunctions have not been widely
studied. However, amygdala-related functions are receiving increasing attention in
neuropsychological diagnostics (Benuzzi et al 2004; Glogau et al 2004; Meletti et al 2003).
The intracarotid amobarbital test (IAT) is currently the most common and reliable method
used to assess lateralisation of memory (Loring et al 2001b). The IAT anaesthetises an
entire hemisphere in order to test the other hemisphere for verbal and visual encoding or
retrieval efficiency. However, this invasive procedure is difficult to repeat and associated
with rare but significant complications. Standard protocols of invasive IAT do not provide
in any patient reliable information because of limited time and because the injected
barbiturate may not always anaesthetise the area of interest. With the use of presurgical
fMRI diagnostics it is hoped that this new technique might supersede the invasive IAT
(Jokeit et al 2001a; Richardson et al 2004). Apart from the fact that fMRI is non-invasive, it
provides the possibility of mapping additional structures such as the amygdala.
Today, fMRI is an attractive tool for examining memory-functions in presurgical
diagnostics due to its wide availability, minimal risk and low costs. Functional MRI
paradigms normally activate the perihippocampal regions bilaterally. Accordingly, the
failure to activate the left or the right MTL indicates impaired function (Vingerhoets et al
2004). A few groups have begun to asses the utility of fMRI for lateralising memory
function in presurgical testing of patients with medically refractory TLE using episodic
memory encoding paradigms with complex visual scenes (Detre et al 1998; Stern et al
1996) or multimodal stimuli (Golby et al 2002; Kelley et al 1998). Jokeit and co-workers
(2001c) have shown that a simple fMRI memory paradigm (Roland’s Home Town Walk)
effectively lateralises the epileptic temporal lobe by activation of the parahippocampal gyri.
The main technical problem of fMRI within the temporal lobes is its susceptibility to
artefacts caused by inhomogenities in the field due to the differing magnetic properties of
bone, tissue and air (Powell and Koepp, 2004). The temporal lobe, with its different
tissues, is therefore especially likely to suffer from geometric distortions or loss of BOLD
signal (Jezzard et al 1999). The latter artefact is serious as signal loss leads to sensitivity
loss. It has been shown that this artefact is most prominent in the inferior frontal and
inferolateral temporal region (Ojemann et al 1997). Susceptibility-induced signal loss is
greater in the anterior relative to posterior hippocampus. This may be the reason for the
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relative lack of anterior hippocampal activation in fMRI studies of memory (Greicius et al
2003). In spite of these difficulties, amygdala imaging might help to boost clinical interest
in amygdala-related functions, as well as improving presurgical diagnostics of MTL for
lateralisation reliability.
Due to its small volume and position in the anterior part of the temporal lobe, the
amygdala is difficult to image with fMRI. Furthermore, the use of a paradigm in a clinical
context requires that the paradigm activates the amygdala sufficiently and provides
reliable, reproducible activations in each individual patient, regardless of their cognitive
status. In recent neuroimaging studies the amygdala showed the largest and most
consistent activation when individuals viewed negative, especially fearful, facial
expressions (Zald 2003), even when unattended (Critchley et al 2000; Gorno-Tempini et
al 2001; Vuilleumier et al 2001). Comparison of static versus dynamic facial presentations
in an fMRI paradigm revealed stronger amygdala activation for dynamic presentations
(LaBar et al 2003). This highlights the importance of temporal cues in the neural coding of
facial expressions. Further, the amygdala participates in biological motion perception such
as eye gaze and body movement perception, even when the stimuli have no apparent
emotional content (Bonda et al 1996; Kawashima et al 1999).
Based on these insights, we developed an fMRI paradigm using visual presentation of
sequences from thriller and horror movies showing actors portraying fearful faces. This
paradigm was aimed at improving presurgical diagnostics in two ways: (1) The use of two
distinctive fMRI-paradigms mapping both the amygdala and the parahippocampal region
might improve the reliability of MTL diagnostics in MTLE patients. (2) In future, presurgical
imaging of the amygdala may allow for the evaluation of possible clinical implications of
amygdala-resections and may thus help to identify candidates at risk of emotional and
social impairment following temporal lobe surgery.
Therefore, the first aim of our study was to investigate the feasibility of imaging the
amygdala in individual cases, including epilepsy patients and healthy volunteers. Second,
we evaluated in healthy volunteers whether the paradigm fulfils prerequisites of clinical
diagnostics such as bilateral, strong, reliable and reproducible activations. And third, we
asked whether the use of two paradigms that activate MTL structures, the fearful face task
and the Roland’s Hometown Walking Task, improves the reliability of MTL diagnostics.
This would require that the fearful face task lateralises hemispheric asymmetries in
epilepsy patients and that this paradigm reveals additional information by observing
dissociations between amygdala and parahippocampal activation.
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5.3.2 Materials and methods
5.3.2.1 Subjects
Seventeen patients (11 male, 6 female) aged 18-58 years with symptomatic focal epilepsy
were investigated (table 3). Twelve of these patients suffered from MTLE (11 hippocampal
sclerosis, one neoplasia) with clear unilateral seizure onset of temporal origin (6 right, 6
left) as shown by continuous interictal and ictal video/EEG monitoring with scalp and
sphenoidal electrodes. Five patients had lesions outside the MTL. Lesions and structural
integrity of non-affected MTL were demonstrated by high-resolution routine MRI.
Language laterality in all patients was defined using an fMRI-paradigm employing verbal
fluency (Jokeit et al 2001b). Eleven epilepsy patients had left-sided, two bilateral and one
had right-sided language dominance (in three patients language dominance was not
available due to excessive head motion during the scan).
Seventeen control subjects (aged 23 to 57 years, mean = 31 (± 7.4 SD) 8 female, 14 right-
handed) were included. Fourteen were self-reported right-handed and three left-handed.
All were healthy with no history of psychiatric or neurological illness and were free of
medication.
In all subjects, including the 17 epilepsy patients and 17 healthy volunteers, amygdala
activation was measured with a fearful face paradigm. In order to test intrasubject
reproducibility, 12 healthy volunteers (5 females, 4 right-handed) were rescanned one to
eight weeks later.
In addition to the fearful face paradigm, parahippocampal activation was measured in the
same session in all patients and in nine of the control subjects (5 female, aged 24-38)
using the Roland’s Home Town Walking Task (Jokeit et al 2001c).
After a complete explanation of the study, all subjects gave written informed consent. The
investigations performed here were in compliance with the code of ethics as stated in the
Declaration of Helsinki and were approved by the local Medical Ethics Committee.
5.3.2.2 fMRI task design
In order to activate the amygdala, we developed a paradigm utilising visual presentations
of dynamic fearful faces. Stimuli were presented in a block-design. The paradigm
consisted of eight activation and eight baseline blocks each lasting 24 seconds. The
activation condition consisted of 75 brief episodes (2-3 sec) from thriller and horror films.
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All episodes showed the faces of actors who were expressing fear with high-intensity.
None of the episodes showed violence or aggression.
Quality and applicability of film sequences were evaluated by an expert panel consisting
of nine psychologists. Out of an initial collection of 120 scenes, only sequences that were
considered appropriate by the majority of the expert panel were extracted for the
paradigm. Evaluation criteria were as follows: (1) actor’s face is clearly visible (2) emotion
displayed is clearly recognisable as fear (3) fear is the only clearly recognisable emotion,
no other emotion (e.g. anger, sadness, surprise) is displayed, and (4) the fear displayed is
of high intensity.
During baseline blocks, 72 short episodes of similar length (2-3 sec) with dynamic
landscape video recordings were presented. Video clips of dull domestic landscapes were
used due to their stable low emotional content while general visual stimulus properties
were comparable to the movie clips. Frequency and duration of the sequences (2-3 sec)
were matched for activation and control conditions. Stimuli were presented via a back-
projection screen, viewed through a tilted overhead mirror. Prior to beginning, subjects
were told that they would see rapid presentations of film sequences depicting fearful faces
intermixed with landscape film sequences. They were instructed to relax while watching
the film and to focus on the eyes of the actors during the activation blocks. After the scan,
subjects were asked to rate the emotional involvement they felt on a continuous scale
from zero to ten. Furthermore, subjects were asked to indicate which movies they
recognised.
Roland’s Hometown Walking Task (Woermann et al 2003) was used to induce memory-
related activation within the MTL. The paradigm consisted of ten activation blocks and ten
baseline blocks, each with a duration of 30 seconds. During the activation blocks, subjects
were required to retrieve spatio-temporal information from long-term memory. For each
subject, an individual hometown walk encompassing ten destinations was prepared.
Subjects were asked to mentally navigate through the ten different routes and to imagine
as many details as possible while navigating. After 30 seconds each route was interrupted
by the baseline task. The baseline condition consisted of silently counting odd numbers
starting with 21.
We used a verbal fluency task (Woermann et al 2003) to determine language dominance.
In each patient, 50 sets of images sampled during five episodes of silent word generation
were contrasted with 50 sets of images from 5 episodes of resting inactivity (patients were
instructed to stop producing words) using a block design.
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5.3.2.3 MR image acquisition
Structural and echo planar imaging functional images were acquired on a 1.5 Tesla
Magnetom Sonata Scanner (Siemens, Erlangen, Germany). Subjects were positioned in
the head coil with ear pads and foam padding to reduce head motion.
A high resolution T1-weighted anatomical scan was acquired for each subject for
reference in single-subject analysis. The parameters for the anatomical sequence were as
follows: 176 axial slices with 1mm single-slice thickness, repetition time (TR) 1900ms,
echo time (TE) 3.93ms, 15° flip angle, field of view (FOV) 250mm, 256 x 256 matrix.
Functional data were acquired using EPI T2* weighted sequence. The following
parameters were applied to measure amygdala activation: 12 coronal slices, 5mm slice
thickness (interslice gap: 1mm), repetition time (TR) 1490ms, echo time (TE) 60ms, 90°
flip angle, field of view (FOV) 250mm, matrix size 64 x 64 (voxel-size 3.9 x 3.9 x 5mm),
reconstructed into an image matrix of 128 x 128. Coronal slices were oriented orthogonal
to the hippocampal formation and covered the anterior TL.
In Roland’s Hometown Walking Task and the word generation paradigm the following
parameters were applied: 21 slices, 5mm slice thickness (interslice gap: 1.2mm),
repetition time (TR) 3000ms, echo time (TE) 50ms, 90° flip angle, field of view (FOV)
250mm, size 64 x 64 (voxel-size 3.9 x 3.9 x 5mm), reconstructed into an image matrix of
128 x 128. In Roland’s Hometown Walking Task coronal slices were oriented orthogonal
to the hippocampal formation and in the word generation paradigm, axial slices were
oriented longitudinal to the AC-PC.
5.3.2.4 Data analysis
fMRI data analyses were performed with BrainVoyager 4.9.1 (BrainInnovation, Maastricht,
The Netherlands). Prior to analysis, the data were pre-processed with (1) three-
dimensional motion correction and (2) trend removal by temporal fast Fourier transform-
based high-pass filtering and transformed into Talairach co-ordinate space (Talairach et al
1988). Images of the fearful face task were additionally spatially smoothed with a full width
at half maximum of 4mm.
For multiple regression analysis, a general linear model (GLM) with the predictor for the
activation condition was computed. The time courses of the predictor were obtained by
using a linear model of the haemodynamic response. The overall model fit was assessed
using an F statistic. Significant differences between the experimental conditions were
assessed using contrast (t) maps.
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Language lateralisation was determined visually by evaluation of frontolateral and
temporoposterior lateral as well as parietal and frontomesial activation for asymmetry with
individual statistical thresholds (Woermann et al., 2003).
For images in the fearful face task, individual volumes of interests (VOIs) were defined for
the amygdalar region. VOIs were specified functionally in each patient separately on a
predefined statistical threshold of p < .001 (z > 3). This threshold accounted for the small
size of the periamygdalar region. The size of the periamygdalar region was between 60
and 100 voxels (3.9 x 3.9 x 5mm). A threshold of z > 3 ensured that the error probability
for a single activated voxel within the region of interest is smaller than 0.05 (one-tailed
test). Anatomical border of the functional clusters was the uncal recess caudally and the
optical chiasm rostrally and white matter superiorly. For each VOI, the number of activated
voxels was counted in the left and right hemisphere.
The same method was used for parahippocampal VOIs in Roland’s Hometown Walking
Task. The predefined statistical threshold was defined as p < .00001 (Jokeit et al., 2001c)
and the functional cluster was caudally constrained by the crus of the fornix.
In epilepsy patients and healthy volunteers, lateralisation indices (LI) were defined for
number of significantly activated voxels within parahippocampal gyrus and amygdalar/
periamygdalar region using the formula:
LI = (right-left) / (right + left)
The categorisation of memory lateralisation was defined based upon the results of the
healthy volunteers. The mean of LI in healthy volunteers was .05 (± .18 SD). If the LI was
greater than 0.23 or less than -.13 we categorised these cases as lateralised memory re-
presentation. The mean LI of the amygdala was .23 (± .24 SD). If the LI was greater than
.47 or less than -0.01 we categorised these cases as lateralised amygdala representation.
For healthy volunteers, data from the fearful face task were evaluated with respect to
reliability, strength and reproducibility of activation. Reliability of activation was
investigated with a conjunction analysis over all 17 subjects. To collect percent BOLD
signal change data within the amygdala, VOIs with similar cluster sizes were defined
using the following method: A conjunction analysis was computed to define the region in
which every single subject revealed significantly activated voxels. Then, individual VOIs
were defined by applying a cube with the size of 125 voxels (1mm3 isotropic voxels) in the
centre of the activation in order to cover the most activated voxels . Individual VOIs were
used in order to account for anatomical differences among subjects. Within these defined
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VOIs, time course epochs corresponding to the conditions were averaged together and
peak of percent BOLD signal change was collected for each subject.
To analyse reproducibility of the amygdala-paradigm, we looked for between-session
habituation effects and different test-retest reliability estimates. Between-session
habituation was analysed using RMANOVA with the factors ‘significantly activated voxels’
and ‘percent BOLD signal change’. Additionally, ROI GLM analysis with separate study
predictors were performed. The ROI based time courses were then statistically evaluated
for the contrast first measurement versus second measurement. This contrast was tested
using t-statistics.
To estimate test-retest reliability we computed intraclass correlation coefficient (ICC) and
percentage overlap (Rijoverlap). ICC was used to quantify the reliability of activation extent
(significantly activated voxels) and activation intensity (percent BOLD signal change). ICC
represents the difference between within- and between-subject variability and it
approaches 1 when within-subject variability is low. Most of the observed variance can
then be explained by between-subject variability (Specht et al 2003). Rij overlap was used
to investigate test-retest reliability of activation location. Rijoverlap between two activation
maps was calculated as follows (Rombouts et al 1998):
Rijoverlap = 2*Voverlap / Vi + Vj
Voverlap was the volume activated in both the first and second measurement. Vi indicates
the number of activated voxels in the first measurement, V
 j in the second measurement.
5.3.3 Results
In all subjects, including the 17 epilepsy patients and 17 healthy volunteers, significant T2*
contrast differences were found within the amygdala (p < .001) in response to watching
fearful faces from horror and thriller movies in contrast to watching landscape scenes. The
activation focus was located in the superior part of the amygdala (Talairach co-ordinates:
20 –4 –8 (right) and –20 –5 –7 (left)).
Characteristics regarding the clinical usefulness of the fearful face paradigm were first
evaluated in healthy volunteers. The fearful face task led to significant bilateral activation
in every control subject as demonstrated by significant voxels in this region following
conjunction analysis (p < .05, figure 15).
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Figure 15: Conjunction analysis of the amygdala-activations induced by the fearful face task in healthy
volunteers. Overlap maps denote bilateral significantly activated voxels within the amygdala in all
17 healthy volunteers (p < .05).
The mean percent signal change of the BOLD response relative to baseline was 1.09%
(± .30 SD) in the right and .81% (± .28 SD) in the left amygdala. Significant changes of
BOLD response in single subject exceeded 0.67% (± .20% SD) within the right amygdala
and 0.51% (± 0.22% SD) within the left amygdala. Activation intensity was not correlated
with self reported strength of emotional involvement (p > .33) or recognition of movie
sequences (p > .60), whereas recognition of movies and felt emotional involvement was
negatively correlated (r= -.52, p < .05).
Bilateral amygdala activations were reproducible in all 12 subjects. The number of
significantly activated voxels and percent BOLD signal change for both measurements
were comparable for all twelve subjects (figures 16 and 17). There was no between-
session change in the number of significantly activated voxels (RMANOVA right MTL: F
(df = 1, n = 12) = 2.87, p = .12, eta2 = .20, Power = .34 and RMANOVA left MTL: (F (df =
1, n = 6) = .005, p = .95, eta2 = 0, Power = .05) or percent BOLD signal change
(RMANOVA right MTL: F (df = 1, n = 12) = .17, p = .32, eta2 = .13, Power = .22,
RMANOVA left MTL: F (df = 1, n = 12) = .53, p = .51, eta2 = .11, Power = .09). In addition,
the ROI GLM analysis revealed no significant differences for the contrast ‘first
measurement versus second measurement’ over all subjects (left amygdala: p = .98; right
amygdala: p = .42). Retest-reliability, as measured by ICC, was high for significantly
activated voxels (right: ICC = .92, p < .0001; left: ICC = .79, p < .005) and percent BOLD
signal change (right: ICC = .69, p < .05; left: ICC = .83, p < .005). The relative amount of
overlapping volumes demonstrates that the measurements constantly activated voxels in
the amygdala which were significantly activated during both the first and the second
measurement. Depending on the threshold chosen, slightly different percentages of Rij
overlap were found. Mean overlap with p < .001 = .36 (± .19 SD), with p < .005 = .39 (±
.18 SD), and with p < .01 = .46 (± .19 SD).
E
xp
e
rim
e
ntal
 studies:
 Third
 study69
LI
(p<.00001)
-.61
-1
-.79
-.48
-.92
.32
.48
-.23
.77
.40
.44
.52
.23
-.01
0
.05
.22
Parahipp.
activation
left > right
unilat. left
left > right
left > right
left > right
right > left
right > left
Left > right
right > left
right > left
right > left
right > left
bilateral
bilateral
bilateral
bilateral
bilateral
LI
(p<.001)
.08
-1
-.78
-.28
-1
-1
1
1
.96
1
1
.8
-.35
.02
.15
.34
-.25
Amygdala
activation
bilateral
unilat. left
left > right
left > right
unilat. left
unilat. left
unilat. right
unilat. right
unilat. right
unilat. right
unilat. right
unilat. right
bilateral1
bilateral
bilateral
bilateral
bilateral1
Language
left
n.a.
left
left
left
bilateral
left
left
left
left
left
left
right
n.a.
left
n.a.
bilateral
Duration of
epilepsy (y)
37
25
11
3
3
45
30
8
26
43
35
20
1.5
5
16
1
.5
4
0
7
27
18
11
1
37
7
4
9
13
19
15
22
44
39
     Age at seizure
     onset (y)
Morphologic
lesion
HS
HS
HS
HS
Amygdala lesion
HS
HS
Tumour
HS
HS
HS
HS
Perinatal damage
within left sylvian
fissure
Cortical atrophy
frontal/dorsoparietal
n.a. (TL not affected)
Meningeoma parieto-
occipital
Resected Oligo-
dendroglioma within
left paracentral gyr.
Side of
seizure onset
right
right
right
right
right
right
left
left
left
left
left
left
left
left
n.a.
left
left
Type of
epilepsy
MTLE (th. r.)
MTLE
MTLE (th. r.)
MTLE
MTLE (th. r.)
MTLE (th. r.)
MTLE (th. r.)
MTLE (th. r.)
MTLE
MTLE
MTLE (th. r.)
MTLE
TLE
FLE
n.a.
PLE
PLE
Table 3:        Demographic and clinical data for the patients studied
Pat.
A1
A2
A3
A4
A5
A6
B1
B2
B3
B4
B5
B6
C1
D1
D2
D3
D4
n.a. not available; MTLE (th. r.) = Mesial temporal lobe epilepsy (Therapy refractory); TLE = Temporal lobe epilepsy; PLE = Parietal lobe epilepsy; FLE = Frontal lobe
epilepsy; HS = Hippocampal sclerosis; LI = Lateralisation index; 1reversed LI is presumed due to atypical language dominance
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Figure 16: Scatterplot of significantly activated voxels induced by the fearful face task during the first and
the second measurement. Note the high reproducibility of the significantly activated voxels within
the amygdala.
Figure 17: Scatterplot of percent BOLD signal change induced by the fearful face task during the first and
the second measurement. Note the high reproducibility of the percent BOLD signal change
within the amygdala.
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The clinical usefulness of the fearful face paradigm was further analysed with regard to
the explanatory power of lateralisation in epilepsy patients as compared to controls. The
bilateral amygdala-activation in control subjects (mean of LI = .23 (±. 24 SD)) and patients
without MTLE was slightly asymmetric to the right side, but did not significantly differ from
zero. In contrast, eleven of the 12 patients with MTLE showed clearly lateralised
amygdala activation contralateral to the side of seizure onset (figure 18). Seven of these
patients had even unilateral amygdala activation (Table 3).
Figure 18: Plot of lateralisation indices of patients and controls. Note lateralised amygdala activation
contralateral to the side of seizure onset in MTLE patients. In contrast, patients with epilepsy
other than MTLE and healthy volunteers revealed lateralisation indices around zero.
The lateralisation indices of the amygdala were compared with activation induced by the
Roland’s Hometown Walking Task in the parahippocampal gyrus. In nine out of twelve
patients, asymmetries of amygdala activation and parahippocampal activation were in
accordance with asymmetries of parahippocampal activation (Table 3). Figure 19 exempli-
fies typical activation patterns in one patient with left- and one patient with right-sided
MTLE.
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Figure 19: Example of a typical activation pattern within amygdala (left) and parahippocampal gyri (right) in
left (above) and right-sided MTLE (below). Above: asymmetric activations contralateral to the
seizure onset in a 33-year old woman with left-sided hippocampal sclerosis (left-sided language
dominance, seizure onset at 13 years). Below: asymmetric activations contralateral to the side of
seizure onset in a 25-year old man with right-sided hippocampal sclerosis (left-sided language
dominance, seizure onset at 0 years).
Figure 20: Example of dissociated activation pattern in amygdala (left) and parahippocampal gyri (right) in
left-sided MTLE (above) and right-sided MTLE (below): Above: asymmetric amygdala activation
contralateral to side of seizure-onset and reversed parahippocampal activation in a 45-year old
man with left-sided MTLE (left-sided language dominance, seizure onset at 37 years). Below:
amygdala was bilaterally activated while parahippocampal activation was asymmetric
corresponding to the side of MTLE in a 41-year old man with right-sided hippocampal sclerosis
(left-sided language dominance, seizure onset at 4 years).
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In three patients we found dissociated amygdalar and parahippocampal activations.
Dissociations were found in two directions: with unilateral amygdala and reversed
asymmetries in parahippocampal activations (patient B2 with left (figure 20, above) and
patient A6 with right-sided epilepsy) and bilateral amygdala-activation and asymmetric
parahippocampal activation (patient A1 with left-sided MTLE; figure 20, below).
Finally, we analysed whether combining both the fearful face task and Roland’s
Hometown Walking Task improved the reliability of lateralisation in MTLE. Both paradigms
were plotted against each other with LI of the parahippocampal gyrus (induced by
Roland’s Hometown Walking Task) on the x-axis and LI of the amygdala induced by the
fearful face task on the y-axis (figure 21). The combination of both tasks separated MTLE
patients from epilepsy patients other than MTLE and healthy volunteers.
Figure 21: Lateralisation indices of the activations within parahippocampal gyrus (induced by Roland’s
Hometown Walking Task) and within amygdala (induced by the fearful face paradigm). The
activation clusters of both paradigms separate patients with MTLE from healthy subjects and
from patients with epilepsy other than MTLE
Experimental studies: Third study
74
5.3.4 Discussion
This study investigated the feasibility, clinical usefulness and practicality of using fMRI
imaging of the amygdala in individual patients with a fearful face paradigm. By using this
paradigm in addition to Roland’s Hometown Walking Task we hoped (1) to improve the
reliability of MTL diagnostics in patients with refractory temporal lobe epilepsy and (2) to
provide an imaging procedure that permits the evaluation of possible clinical implications
for amygdala-related functions following temporal lobe surgery.
The feasibility of imaging the amygdala in individual cases was demonstrated by
significant T2* contrast differences in the amygdala in response to watching sequences
from thriller and horror movies showing actors portraying fearful faces in contrast to bland
domestic landscape recordings. Amygdala activations were found in all subjects, including
17 epilepsy patients and 17 healthy volunteers. The activation focus was located in the
upper portion of the amygdala, as has been reported in the literature (Breiter et al 1996;
Pessoa et al 2002; Phillips et al 1997; Whalen et al 1998; Williams et al 2001). It should
be mentioned that the procedure presented here was not aimed at identifying certain brain
regions purported to be responsible for amygdala-activation by a single cognitive process.
There is converging evidence, however, that motion (LaBar et al 2003), human faces in
general and especially fearful facial expressions (Zald 2003) induce amygdalar activation
in fMRI-experiments. Therefore, we conclude that the combination of these processes and
the highly fitting context led to the considerable amygdala-activation we observed in our
study.
An additional advantage of our paradigm for clinical applications is that it does not
demand complex cognitive abilities, and that it can even be used in mentally impaired
patients. The amygdala paradigm is easy to administer using commercially available
equipment. Measurement of performance is not required, as the activation strength was
not influenced by measured emotional involvement. This might be due to the fact that
processing of fear-related sensory stimuli in the amygdala is highly automated (Dolan et al
2003). This has been reported in previous neuroimaging studies which found consistent
activations in response to unattended fearful faces (Morris et al 2001).
The fearful face paradigm was analysed with regard to clinical features such as reliability,
strength and reproducibility of activation in healthy volunteers. We found consistent and
strong bilateral amygdala-activations in all 17 healthy volunteers. Cluster sizes were large
enough to be detected in each individual. The reproducibility of amygdala activation was
investigated by measurement-repetition in 12 healthy subjects. The activation extent and
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strength was not reduced by repetition, although subjects remembered having seen the
same scenes before. This suggests that there was no between-session habituation either
in the number of significantly activated voxels or percent BOLD signal change. This
finding apparently contradicts results of earlier studies showing that amygdala responses
rapidly habituate (Zald 2003). This pattern of habituation has also been observed in fMRI
experiments (Breiter et al 1996; Phillips et al 2001; Thomas et al 2001; Wright et al 2001).
However, in contrast to our experiment, these studies used experimental designs with a
single scan and static stimulus material. Furthermore, we found stable activation patterns
in signal intensity and spread, indicated by high intraclass correlation coefficients. Retest-
reliability of activation location was measured by the relative amount of overlapping
activated voxels in two measurements, indicated by percentage overlap (Rijoverlap). Overlap
indices were only slightly lower compared to previous reported results of a language task
(Fernandez et al 2003) and of an unattended primary visual task (Specht et al 2003).
These findings could be due to the fact that the amygdala region is considerably smaller
than the visual and language areas studied by these authors.
The fearful-face paradigm was then evaluated with regard to lateralisation-power. We
found consistently strong and reliable bilateral amygdala activations in healthy volunteers
and in patients with epilepsy not originating within the MTL. In contrast, the majority of
MTLE-patients revealed clear interhemispheric asymmetries in amygdala activations,
indicated by absent or very small clusters on the pathological side. It should be noted that
the absence of activations was independent of the statistical threshold chosen, that is, no
significant activations were found in activation maps with lower thresholds in those
patients. From a methodological point of view it should be mentioned that individually
adjusted thresholds would be appropriate because of the highly variable activation levels
found in subjects and would, therefore, improve interpretability for patients with
asymmetric activations. Patient A4, for example, elicited a high activation level and
therefore had clearly asymmetric LI at higher thresholds (LI = -.74 on p < .00001),
whereas the predefined threshold revealed weak asymmetry (LI = -.28 on p < .001).
However, we preferred to present our data with predefined thresholds to allow for
comparisons between subjects.
Analyses of amygdala-LI and parahippocampus-LI yielded comparable results. Laterali-
sation indices of amygdala-activation in fourteen out of seventeen patients was in
accordance with memory-induced MTL-activations. Hemispheric asymmetries in the
studied sample were more distinctive in the amygdala than in the parahippocampal gyrus.
This could reflect possible dissociations which have been shown in structural studies.
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Amygdala and hippocampal sclerosis are usually combined, but the sclerosis may also be
solely restricted to the hippocampus or amygdala. This is one possible explanation for the
findings in our first patients with a functional dissociation, in which the parahippocampus
was active bilaterally while the amygdala was active unilaterally. On the other hand, the
amygdala may escape the sclerotic process and be activated bilaterally, whereas
activation of the parahippocampal region is clearly lateralised as shown in our second
case of a dissociation. Further comparative studies of pathology of postoperative
specimens might give us an explanation for the observed dissociation. This double
dissociation of parahippocampal and amygdalar activation indicates that the paradigms
used provide independent and supplementary lateralisation-information. This specificity is
an important feature if the paradigm is to be used in a clinical context.
The combination of the fearful face task and the Roland’s Hometown Walking Task,
finally, highly increased the reliability of lateralisation in MTLE-patients. The increased
reliability of functional MTL diagnostics may help to replace invasive IAT procedures by
fMRI (Janszky et al 2005; Richardson et al 2004).
To summarise, the fearful face task presented here seems to be highly suitable for
studying the amygdala in individual cases due to its reliability, reproducibility, specificity
and lateralisation-power. The additional use of Roland’s Hometown Walking Task
improves presurgical diagnostics by increasing the reliability of lateralisation in patients
with refractory MTLE. In addition, imaging the amygdala in a clinical context permits the
evaluation of possible implications that temporal lobe surgery could have on various
emotional and social variables.
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6 General discussion and conclusion
The present report was aimed at investigating clinical fMRI applications within the mesial
temporal lobe (MTL). These applications were designed to improve the clinical fMRI
diagnostics in MTL epilepsy (MTLE). Comprehensive MTLE diagnostic includes the
evaluation and prevention of negative treatment effects on patients’ cognitive profiles. This
is provided by neuropsychological examination and, increasingly, by fMRI. Mesial
temporal lobe epilepsy is mainly treated with antiepileptic drugs (AED) or, when the
seizures are refractory, by resective surgery. Both therapies may have substantial
influence on cognition. The importance of evaluating cognitive side-effects of treatments is
based upon the experience that impaired cognitive functions are one of the major
influences on quality of life in individuals with epilepsy (Trimble 1994).
The studies reported here addressed three selected topics in the field of clinical fMRI
within MTL. The first study approached a more technical question of fMRI. One of the
major difficulties in using fMRI in a clinical context is the low BOLD contrast in individual
subjects, and especially within MTL, where the SNR is genuinely low. Because caffeine
has recently been proposed as an effective BOLD contrast booster in functional MRI
studies for studies confronted with a low SNR (Mulderink et al 2002), we attempted to
evaluate caffeine as a contrast booster for single-case fMRI-investigations.
The second study was aimed at improving the evaluation of pharmacological treatment of
epilepsy. Antiepileptic drugs may have substantial cognitive side-effects. To date,
neuropsychological examination has been the major method for objectively examining
cognitive functions related to the use of AEDs. Functional MRI may improve diagnostics of
pharmacologically induced cognitive side-effects. Before this can be realised, the fMRI-
method needs to be validated with respect to the long-term reproducibility of the results.
The second study was therefore aimed at investigating the intra-individual variability of
serial fMRI-scans.
Probably the most important and the most advanced clinical application of functional MRI
is found in the presurgical diagnostics of medically refractory MTLE patients. Functional
MRI has been used to examine regional changes in brain function associated with
seizures. The approach of functionally investigating the brain is based upon the fact that
epilepsy is in many instances a functional disorder that must not necessarily be
accompanied by gross abnormalities in structural imaging. In presurgical evaluation, fMRI
is used mainly to assess localisation and lateralisation of language and memory to
prevent postsurgical impairments. The third study was aimed at providing an fMRI
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application to investigate additionally the amygdala. This could improve the reliability of
MTL diagnostics in MTLE patients and may in future allow for the evaluation of possible
clinical implications of amygdala-resections, such as emotional and social impairment
following temporal lobe surgery.
6.1 Evaluation of the aims
6.1.1 First study
The first study, investigating whether caffeine might be used as a BOLD contrast booster
in clinical studies, uses a single case, placebo controlled, repeated fMRI study design. Six
healthy volunteers performed eight fMRI sessions on four different days. Each study day
consisted of a pretreatment session prior to the application of placebo or caffeine and a
post-treatment session. Each fMRI session included a visual, a motor and a memory task.
The first aim of this study was to replicate previously reported group results, where
caffeine obviously boosted the BOLD contrast within the primary motor and the visual
area (Mulderink et al 2002). We hypothesised that the application of caffeine is efficient to
boost the BOLD contrast on a single case level. The study confirmed through group
analyses that 200mg caffeine enhanced the BOLD-contrast in M1 during the performance
of a motor task (ROI-GLM: p < .001), however the more conservative repeated measures
ANOVA failed to confirm this result (p = .09). Caffeine increased the inter-individual
variability of percent BOLD signal change compared to the baseline condition. We failed
to reproduce the reported signal increase following administration of caffeine in V1.
Instead, group analyses showed that caffeine decreased the BOLD-contrast in V1 (p <
.00001). At an individual level we found increases as well as decreases in the BOLD-
signal in V1. This was statistically confirmed by applying a RMANOVA model (p = .81).
The second aim of the study was to investigate whether caffeine does enhance the BOLD
contrast within MTL and we explored whether enhancing effects will be observable on a
single-case level. We found within the MTL no significant change following caffeine intake,
neither for group analyses (p = .65) nor in the RMANOVA (p = .20).
It should be mentioned that a higher dose of caffeine would be more effective in
influencing the BOLD signal. The 200mg dose was in our study chosen in accordance to
Mulderink and co-workers (2002) and Laurienti and co-workers (2002) who administered a
caffeine dose in this range, namely 200mg (Mulderink et al 2002) and 250mg (Laurienti et
al 2002). However, a higher dose is not practical in a clinical setting due to adverse side-
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effects. It has been reported that subjects felt jittery, anxious or nervous after the admini-
stration of doses exceeding 300mg (Evans et al 1991).
One should take into account that our results are based on a small sample. However, it
was our intention to investigate intra-individual effects of caffeine administration. The use
of caffeine as a BOLD contrast booster in a clinical context requires reliable successive
results in each individual subject. Previous studies referred to group designs without
administration of both placebo and caffeine conditions (Mulderink et al 2002) or pre- and
posttreatment caffeine conditions within a single subject (Laurienti et al 2002). In contrast,
we chose an extended study design with each person acting as their own control in four
baseline, two placebo and two caffeine measurements.
To summarise, caffeine seems to be far less effective as a BOLD contrast booster than
expected, although previous studies found boosting effects on the BOLD response
following caffeine administration. Our results discourage the use of caffeine in a clinical
context as it may enhance inter-individual variability and may even reduce the signal in
certain subjects. Moreover, in our study caffeine related BOLD-contrast changes were
clearly domain specific within individual subjects.
6.1.2 Second study
The second study investigated the longterm-reproducibility of serial fMRI scans within the
MTL. Six healthy volunteers were examined six times with a modified version of the
Roland’s Hometown Walking Task (Jokeit et al 2001c). The scans were performed on four
different days with intervals of 1-4 weeks.
First, we aimed to describe the magnitude of variability of MTL activations over serial
scans both in single-subjects and in group analyses. On single-subject level, we found a
high variability, indicated by high variance coefficients in the significantly activated voxels
and the percent BOLD signal change. None of the studied subjects revealed stable results
over all repeated scans. Our study clearly demonstrated that quantitative interpretation is
not a reliable method of studying longterm effects of brain function at single-subject level.
In contrast, the results on the group level were more promising. We found reasonable
reproducibility and sufficient intraclass correlation coefficients. Nevertheless, the observed
amount of variance was considerable and could not be explained by several
experimentally (e.g. diurnal factors, cycle phase, nutrition habits, drug intake) or
statistically controlled variables (e.g. repetition or behavioural effects). Knowledge about
the magnitude of variability can help in future AED studies to distinguish between
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variations inherent in the examination method and changes in the subject’s brain induced
by pharmacological treatment.
Second, we explored whether the magnitude of the observed variability would allow future
investigations of treatment effects of AEDs on the MTL. The considerable amount of
variability in fMRI-data over a series of scans implies that meaningful data can only be
expected when strong treatment effects are present. The averaged relative deviations
between scans in our study was between 30% and 40%. Two recent pharmacological
fMRI studies probably used potent substances and therefore observed substantial
variations in the BOLD response (Jokeit et al 2001b; Sperling et al 2002). Both of the
anticholinergic drugs lorazepam and scopolamine (Sperling et al 2002) and the
antiepileptic drug carbamazepine (Jokeit et al 2001c) decreased the BOLD signal within
the MTL. Compared to a placebo-condition, lorazepam and scopolamine decreased the
significantly activated voxels within the hippocampus by approximately 40-60% and the
percent BOLD signal change by approximately 50-60%. When only high doses of
carbamazepine (serum levels of more than 7 mg/l) are included, the proportion of
significantly activated voxels within the MTL was decreased by approximately 50% as
compared to a control group. Using serial scans and group analysis therefore appears to
be a realistic method for investigating cognitive side-effects of AEDs on the MTL.
To summarise, we observed highly variable fMRI results on single-case level. The
quantitative interpretation is therefore not a reliable method to individually diagnose AED
changes on brain functions. However, at a group level, we found sufficient reproducibility.
The results do not discourage the application of serial investigations to study the influence
of long-lasting AED treatments. But to date, the application is limited to its use in
longitudinal group studies and to the evaluation of strong influences on the brain
functions, such as could be expected with high doses of AEDs.
6.1.3 Third study
The third study investigated the feasibility and usefulness of imaging the amygdala. We
developed a fearful face fMRI-paradigm that included the visual presentation of
sequences from thriller and horror movies showing actors portraying fearful faces. First,
we aimed at evaluating the feasibility of imaging the amygdala in single subjects and
investigated 17 patients with symptomatic focal epilepsy (12 had MTLE (6 right- and 6 left-
sided)) and in 17 healthy control subjects. The fearful-face paradigm led to significant
activations (p < .001) of the amygdala in all subjects, including 17 patients with sympto-
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matic focal epilepsy (12 had MTLE (6 right- and 6 left-sided)) and 17 healthy control
subjects.
Second, it was aimed at investigating whether the paradigm used fulfils prerequisites of
clinical diagnostics. The results clearly demonstrated, that the paradigm fulfilled pre-
requisites of strong and reliable activations observed in all studied subjects. Additionally,
reproducibility of amygdala activation was demonstrated by restudying 12 of the control
subjects one to eight weeks later. We found stable activation patterns indicated by high
interclass correlation coefficients and considerable retest-reliability of activation location,
measured by the relative amount of overlapping activated voxels in two measurements.
The easy administration and the low cognitive demand on patients increases the
practicality of this tool for studying amygdala-functions and deficits in a clinical context.
Even more, measurement of performance is not required, as far as in our study the
activation strength was not influenced by measured emotional involvement. This might be
due to the fact that processing of fear-related sensory stimuli in the amygdala is highly
automated (Dolan et al 2003).
Third, it was attempted to investigate whether two distinctive MTL paradigms improve the
reliability of MTL diagnostics. We therefore additionally measured parahippocampal
activations using the Roland’s Home Town Walking Task (Jokeit et al 2001c) within the
same session in all 17 patients and in nine of the control subjects. Amygdala activations
were clearly lateralised in MTLE patients and bilateral in control subjects, including
patients with epilepsy other than MTLE, and healthy volunteers. Comparing the results of
the fearful face paradigm with the results obtained by the Roland’s Hometown Walking
Task, we found double dissociated activations of amygdalae and parahippocampi in three
MTLE patients, indicating that these tests provide independent and specific information.
Finally, combining both paradigms highly improved the reliable lateralisation of the
epileptogenic focus in MTLE.
To summarise, the aims of the third study were clearly fulfilled. The amygdala activation
brought on by our fearful face paradigm was strong, robust, reproducible, and specific in
individual subjects. The feasibility of imaging the amygdala in individual cases allows one
to evaluate possible clinical outcomes of amygdala-related functions such as emotional
and social functioning following TL surgery. The combination of the fearful face paradigm
and the Roland’s Hometown Walking Task increases the reliability of lateralisation in
MTLE patients and thus provides a more detailed and reliable presurgical mapping of MTL
structures.
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6.2 General discussion and outlook
The highest benefit for clinical fMRI diagnostics from the present thesis is certainly the
demonstrated feasibility of imaging the amygdala in a clinical context. The highly
increased reliability of lateralisation by the use of two distinctive paradigms, the fearful
face paradigm and the Roland’s Hometown Walking Task, is extremely useful in the field
of presurgical diagnostics of refractory MTLE-patients. The increased lateralisation-power
may help to decrease the number of invasive and risky IAT procedures. To date, fMRI of
memory-lateralisation is far from replacing the invasive IAT. With recent procedures, the
reliability of lateralisation was no higher than about 90% (Killgore et al 1999). Therefore,
our results of increased lateralisation-power are promising. Certainly this method
demands further external validation regarding the predictive value of fMRI for postsurgical
outcome. It still needs to be demonstrated that the fMRI procedure of applying both
paradigms reveals typical and atypical results in large numbers of individual cases in
agreement with a standard, i.e. the IAT in presurgical diagnostics or the postoperative
outcome. When prospective studies are clearly able to demonstrate that resection in a
region of fMRI activation results in a deterioration in memory performance, fMRI data
could be used in planning specific resections in individual cases. Accordingly, recent
preliminary studies have demonstrated the feasibility of assessing the fMRI memory
activation in predicting postsurgical memory performance in TL patients (Janszky et al
2005; Richardson et al 2004). Additionally, fMRI results from ten left-sided MTLE patients
provided a stronger predictor of memory outcome after surgery as compared to other
measures, i.e. the hippocampal volume and pre-operative verbal memory function.
The greatest impact of the amygdala-study is the possibility to evaluate the implications
that temporal lobe surgery could have on various emotional and social variables. At first
glance, epilepsy surgery appears to cause no clinically salient alterations such as
deterioration in psychosocial status. However, the number of controlled studies using
standardised measures to examine social and emotional outcome associated with
epilepsy surgery are few (Hermann 2002) and the emphasis of most studies is on overall
group comparisons. Therefore, a closer examination of surgical patients may reveal
individuals who show no improvement and may even deteriorate in terms of psychosocial
status (Hermann 2002). In children and young adults, however, low occupational or
educational status (Keene et al 1998) and long-term problems in social functioning (Jalava
et al 1997; Williams et al 1998) have been reported, even when seizures are eliminated or
significantly reduced. However, problems in emotional processing, including social
behaviour and cognition following unilateral TL surgery, seem to be more subtle and
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psychometrically difficult to detect and are probably limited to specialised functions.
Recent studies in epilepsy patients have suggested impaired abilities in social perceptual
skills such as recognition of negative emotions from facial expressions (Adolphs et al
2001; Anderson et al 2000). Others have found no deterioration in theory of mind-tests,
including reasoning about the mental states of others, in subjects who sustained surgical
damage to a previously normal amygdala in adult life (Shaw et al 2004). In contrast to the
controversial results following unilateral amygdala-damage, bilateral damage has received
more attention in the literature. It is associated with impairments in the conditioning of
autonomic responses (Bechara et al 1995), in emotional memory (Brierley 2004; Cahill et
al 1995), and in social perceptual skills such as recognising facial expression (Adolphs
2003) and emotional behaviour (Tranel et al 1990). Similar to patients with acquired
bilateral amygdala damage, epilepsy patients with dysfunction of the remaining amygdala
could be at risk for impairments in their emotional processing. However, prospective
outcome studies are needed to assess whether the amygdala is involved in patients who
show deteriorations in emotional processing. Imaging the amygdala presurgically may
help to tailor epilepsy surgery in patients with refractory MTLE. Clearly this approach
would require prospective validation, but patients undergoing presurgical evaluation
represent an ideal population to study whether fMRI activations are conclusively related to
specific task function.
The benefit of the present thesis for the improvement of pharmacological treatment
evaluation might be less obvious. In contrast to presurgical diagnostics, the current state
of research regarding the use of fMRI in the evaluation of pharmacological treatments is
far less sophisticated. The use of fMRI in neuropharmacological studies is in its very
beginning, especially for long-acting drugs. In addition, there is little research into the
quantitative reproducibility of serial fMRI results, a substantial prerequisite for such
studies. This is certainly due to the fact that such studies are very time-consuming, costly
and laborious. Additionally, they could turn out to be difficult, because of genuinely high
variability in the fMRI-data due to factors which are not fully controllable (i.e. scanner
stability or physiological influences). Despite this unfavourable situation, the use of fMRI
for examining cognitive side-effects needs to be investigated because of the need for
improved clinical diagnostics and because fMRI allows one to diagnose cognitive side
effects more objectively than traditional neuropsychological examination.
Because of these limitations, the study reported in this thesis had to be directed at more
basic and technical issues, i.e. the longterm-reproducibility of serial fMRI scans within the
MTL both in single-case and in group analysis.
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On single-subject level, the intra-individual variability of fMRI-results within MTL was high
and corroborated previous findings from primary sensory and motor areas (McGonigle et
al 2000; Waldvogel et al 2000). To date, the technical capabilities of fMRI do not allow for
diagnosis of cognitive AED side-effects on an individual basis. One probable solution
would be to interpret the data not quantitatively within one structure but qualitatively, in
terms of the activation pattern. We did not investigate the activation pattern induced by the
Roland’s Hometown Walking Task in areas other than the MTL. There is one study
investigating the qualitative reproducibility of memory-related activation pattern (Miller et al
2002). The authors observed highly variable activation patterns from individual to
individual, but despite these large variations the intra-individual activation patterns were
reliable over time. The authors suggested that individuals may have been using very
different strategies and cognitive processes during the task and those differences were
reflected by different patterns of brain activations. On-off patterns of the MTL activations
might be interesting for studying severe influences on memory-related MTL structures,
where compensation strategies are needed.
By analysing group-results, we found sufficient reproducibility over several scans.
Although the results of group studies are not necessarily representative for each individual
subject, they might improve the diagnostics of pharmacologically induced cognitive
disturbances by diminishing the impact of any confounding variables. For example, the
adverse effects of AEDs on memory may be offset by reductions in seizures and interictal
discharges, because treating the seizures with AEDs may have positive effects on
memory performance. In addition, the effects of AEDs may interact with focal brain
dysfunctions (Durwen et al 1993). Another factor affecting the results is mood, which may
alter the objective memory performance in epilepsy patients (Motamedi et al 2004).
Functional MRI would allow one to directly investigate the functionality of memory-related
MTL structure and to avoid the problem of overt verbal or non-verbal responses that might
be modulated by individual states and traits.
The benefit for pharmacological treatment evaluation is indirect but could aid future
studies of pharmacological treatment effects of AEDs. The study allows one to distinguish
treatment effects from variations inherent in the examination method and is useful for the
planning of study designs. Based on our findings, we recommend the use of longitudinal
group analyses, using serial scans. Longitudinal studies that cover initiation, chronic
administration and withdrawal of AEDs are methodologically robust designs.
Hereafter, it would be most evidently to prove the effects of carbamazepine within the
MTL by using fMRI. A number of studies have shown that high doses have a substantial
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effect on memory and the related MTL structures. Two independent studies, using SPECT
and Doppler sonography have demonstrated decreased cerebral blood flow changes due
to carbamazepine (Futagi et al 1994; Sechi et al 1995). This might also be associated with
reduced cognitive performance. By comparing the variances found in our reproducibility
study with the carbamazepine-effects previously observed in a cross-sectional fMRI study,
we have shown that fMRI would allow one to study cognitive side-effects of AEDs on
MTL-structures.
The benefit for clinical fMRI diagnostics from the caffeine-study, namely boosting the
BOLD signal within the MTL, was far below our expectations. We failed to find any effects
within this area following caffeine administration. Unfortunately, it is precisely the MTL
where a boosting effect from caffeine would be of greatest help for clinical diagnostics. In
contrast to primary sensory and motor regions, where significant percent BOLD signal
changes can be easily and robustly invoked, the BOLD signal within the MTL is by nature
small and difficult to obtain in single subjects (Powell et al 2004). Our results, however,
clearly failed to show any consistent boosting effect of caffeine within the MTL.
However, the activation magnitude induced by the Roland’s Hometown Walking Task
does not necessarily need to be boosted because this paradigm commonly induces
reliable and strong activations within MTL, even when conservative thresholds are used.
The disadvantage of this paradigm, and for block-designs in general, is that it is not
possible to extract brain activations related to correct answers. Event-related paradigms in
contrast, where this goal is achieved, reveal signal changes that are too weak within
single-case fMRI in MTL. The use of caffeine would have been a very easy and safe
method of boosting the signal and improving clinical diagnostics at 1.5T. However, our
results discount the use of caffeine as a BOLD contrast booster in a clinical context.
Therefore, other approaches such as technical improvements are required to increase the
fMRI-sensitivity for clinical diagnostics. The most realistic approach is probably the
application of higher field strength magnets such as 3T, assuming that its application
becomes practicable for clinical fMRI diagnostics. To date, only one study is available that
demonstrates the possibility of imaging epilepsy patients at 3T (Szaflarski et al 2004). As
the study had a small sample size (no more than six patients), the data are preliminary
and the utility of high field fMRI in a clinical context needs to be investigated in a larger
population.
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6.3 Conclusion
The studies presented here evaluated fMRI paradigms that result in improvements in
clinical diagnostics of MTLE. We were able to considerably improve the presurgical
diagnostics in MTLE patients by demonstrating the feasibility of imaging the amygdala
with fMRI in individual subjects. By employing dynamic fearful faces contrasted by bland
landscapes our paradigm activated both amygdalae strongly, robustly, replicably and
specifically in individual subjects. The ease of administration and the low cognitive
demand on patients increases the practicality of this tool for studying amygdala-functions
and deficits in a clinical context. The feasibility of imaging the amygdala in individual
cases allows for the evaluation of possible clinical implications for amygdala-related
functions such as emotional and social processing following TL surgery. The combination
of the fearful face paradigm and the Roland’s Hometown Walking Task increased the
reliability of lateralisation in MTLE patients and, therefore, provides a more detailed and
reliable presurgical mapping of MTL structures.
Regarding the diagnostics of pharmacologically induced cognitive dysfunctions, we were
able to plan future pharmaco-fMRI studies targeting cognitive side-effects of AEDs. Using
six serial fMRI-scans over several weeks, the present study specified the variability
inherent in the long-term-stability of fMRI results within the MTL. Despite considerable
variability over the scans we suggest that the investigation of long-lasting AED treatments
on the MTL is feasible and reasonable with the use of long-term group studies. Future
studies could improve the understanding of mechanisms, which result in pharma-
cologically induced cognitive disturbances.
The aim of improving the genuinely low BOLD signal within MTL through the use of
caffeine clearly failed. Therefore, other approaches such as technical improvements are
required to increases the fMRI- sensitivity for clinical diagnostics. The most realistic
application is probably the use of higher field strength magnets such as 3T, assumed that
its application becomes practicable for clinical fMRI diagnostics.
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